PARIS, Dec 1 (Reuters) - Below are company-related news and
stories from French and Benelux media which could have an impact
on the region's markets or individual stocks.
Read more
Wednesday, November 30, 2016
Swiss stocks - Factors to watch on Dec 1
ZURICH, Dec 1 (Reuters) - The following are some of the main
factors expected to affect Swiss stocks on Thursday:
Read more
factors expected to affect Swiss stocks on Thursday:
Read more
BRIEF-Lupin Ltd and Eli Lilly expand partnership in India
* Lilly will continue to sell Lispro under the brand name
Humalog through its existing channels
Read more
Humalog through its existing channels
Read more
BRIEF-Shandong Buchang Pharmaceuticals unit ordered to halt production temporarily
* Says its Baoding-based pharmacy unit receives an order
from local environmental protection bureau to halt production
during the period form Nov. 30 to Dec. 31, as response to the
heavy pollution weather
Read more
from local environmental protection bureau to halt production
during the period form Nov. 30 to Dec. 31, as response to the
heavy pollution weather
Read more
UPDATE 3-China manufacturing heats up in November, inflation pressure builds
* Rise of protectionism could hurt investment, trade next
year
(Adds graphic links for PMI trends in China and Asia)
Read more
year
(Adds graphic links for PMI trends in China and Asia)
Read more
UPDATE 2-Rapper Kanye West released from hospital -media reports
LOS ANGELES, Nov 30 (Reuters) - Rapper Kanye West was
released from hospital on Wednesday, according to media outlets
citing unidentified sources, more than a week after he was
admitted for exhaustion.
Read more
released from hospital on Wednesday, according to media outlets
citing unidentified sources, more than a week after he was
admitted for exhaustion.
Read more
Young gay men at the frontline of AIDS prevention in China
BEIJING, Dec 1 (Reuters) - Young gay men are the frontline
of China's battle to prevent the spread of HIV/AIDS, with new
cases in the group increasing fourfold, one of the fastest rates
of any segment of the population.
Read more
of China's battle to prevent the spread of HIV/AIDS, with new
cases in the group increasing fourfold, one of the fastest rates
of any segment of the population.
Read more
PRESS DIGEST- Financial Times - Dec 1
Dec 1 (Reuters) - The following are the top stories in the
Financial Times. Reuters has not verified these stories and does
not vouch for their accuracy.
Read more
Financial Times. Reuters has not verified these stories and does
not vouch for their accuracy.
Read more
UPDATE 1-China manufacturing, services pick up speed in November - official PMI
BEIJING, Dec 1 (Reuters) - Activity in China's manufacturing
sector grew more than expected in November, expanding at its
strongest pace in more than two years, as the world's
second-largest economy picks up momentum heading into what
promises to be a tumultuous 2017.
Read more
sector grew more than expected in November, expanding at its
strongest pace in more than two years, as the world's
second-largest economy picks up momentum heading into what
promises to be a tumultuous 2017.
Read more
GSK biotech asthma drug wins UK approval after extra price cut
LONDON, Dec 1 (Reuters) - GlaxoSmithKline's new
injectable asthma drug Nucala has been recommended for use in
Britain's state-run health service in the most severe patients,
after the drugmaker provided further analyses on its use and
made an additional price cut.
Read more
injectable asthma drug Nucala has been recommended for use in
Britain's state-run health service in the most severe patients,
after the drugmaker provided further analyses on its use and
made an additional price cut.
Read more
UPDATE 1-U.S. House passes 21st Century Cures health bill
Nov 30 (Reuters) - The U.S. House of Representatives on
Wednesday passed a sweeping, $6.3 billion bill that supporters
say will spur medical innovation, speed access to new drugs,
expand access to mental health treatment and battle the opioid
epidemic.
Read more
Wednesday passed a sweeping, $6.3 billion bill that supporters
say will spur medical innovation, speed access to new drugs,
expand access to mental health treatment and battle the opioid
epidemic.
Read more
U.S. House passes 21st Century Cures health bill
WASHINGTON, Nov 30 (Reuters) - The U.S. House of
Representatives on Wednesday passed a sweeping, $6.3 billion
bill that supporters say will spur medical innovation, speed
access to new drugs, expand access to mental health treatment
and battle the opioid epidemic.
Read more
Representatives on Wednesday passed a sweeping, $6.3 billion
bill that supporters say will spur medical innovation, speed
access to new drugs, expand access to mental health treatment
and battle the opioid epidemic.
Read more
UPDATE 2-Cohen's SAC Capital in $135 mln settlement with Elan investors
NEW YORK, Nov 30 (Reuters) - Billionaire Steven A. Cohen's
former hedge fund SAC Capital Advisors LP will pay $135 million
to settle a lawsuit by investors in the drugmaker Elan Corp, who
said they lost money because of insider trading by one of his
portfolio managers.
Read more
former hedge fund SAC Capital Advisors LP will pay $135 million
to settle a lawsuit by investors in the drugmaker Elan Corp, who
said they lost money because of insider trading by one of his
portfolio managers.
Read more
BRIEF-Acadia Healthcare entered into refinancing facilities amendment to its credit agreement
* Acadia Healthcare Company - entered into refinancing
facilities amendment to its amended and restated credit
agreement dated as of December 31, 2012
Read more
facilities amendment to its amended and restated credit
agreement dated as of December 31, 2012
Read more
RPT-U.S. Republicans aim to coax Trump toward House trade tax plan
WASHINGTON, Nov 30 (Reuters) - Republicans in the U.S.
Congress hope to convince President-elect Donald Trump to
support an untested strategy of using the tax code to promote
exports while slashing corporate taxes, framing it as a way to
fulfill his campaign promises to restore blue-collar jobs.
Read more
Congress hope to convince President-elect Donald Trump to
support an untested strategy of using the tax code to promote
exports while slashing corporate taxes, framing it as a way to
fulfill his campaign promises to restore blue-collar jobs.
Read more
BRIEF-Abbvie says investigational IL-23 inhibitor Risankizumab receives Orphan Drug Designation from U.S. FDA
* Abbvie receives Orphan Drug Designation for
investigational IL-23 inhibitor Risankizumab from the U.S. Food
and Drug Administration for the treatment of pediatric patients
with Crohn's Disease
Source text for Eikon:
Further company coverage:
Read more
investigational IL-23 inhibitor Risankizumab from the U.S. Food
and Drug Administration for the treatment of pediatric patients
with Crohn's Disease
Source text for Eikon:
Further company coverage:
Read more
U.S. House poised to pass 21st Century Cures health bill
Nov 30 (Reuters) - The U.S. House of Representatives is
poised to pass a sweeping, $6.3 billion bill that supporters say
will spur medical innovation, speed access to new drugs, expand
access to mental health treatment and battle the opioid
epidemic.
Read more
poised to pass a sweeping, $6.3 billion bill that supporters say
will spur medical innovation, speed access to new drugs, expand
access to mental health treatment and battle the opioid
epidemic.
Read more
Deals of the day-Mergers and acquisitions
Nov 30 (Reuters) - The following bids, mergers, acquisitions
and disposals were reported by 1445 GMT on Wednesday:
Read more
and disposals were reported by 1445 GMT on Wednesday:
Read more
BRIEF-Proclara Biosciences raises $43 mln in equity financing
* Proclara Biosciences Inc files to say it raised $43
million in equity financing - SEC filing
Source text: (http://bit.ly/2gFXTSh)
Read more
million in equity financing - SEC filing
Source text: (http://bit.ly/2gFXTSh)
Read more
Pfizer's Herceptin biosimilar succeeds in key breast cancer study
Nov 30 (Reuters) - Pfizer Inc said on Wednesday its
experimental biosimilar of Roche Holding AG's
blockbuster breast cancer treatment Herceptin met the main goal
in a key study.
Read more
experimental biosimilar of Roche Holding AG's
blockbuster breast cancer treatment Herceptin met the main goal
in a key study.
Read more
BRIEF-H Lundbeck: FDA accepts sNDA for the expanded labeling of Abilify Maintena
* U.S. FDA accepts for review a supplemental new drug
application to expand labeling of Abilify Maintena
(Aripiprazole) for the treatment of Bipolar I disorder
Read more
application to expand labeling of Abilify Maintena
(Aripiprazole) for the treatment of Bipolar I disorder
Read more
BRIEF-Delivra reports Q3 loss per share of c$0.06
* Delivra reports record Q3 revenues and licensing agreement
for the transdermal delivery of medical cannabis during the
quarter
Read more
for the transdermal delivery of medical cannabis during the
quarter
Read more
BRIEF-Pihlajalinna unit acquires MediApu
* Says its unit, Pihlajalinna Terveys Oy, buys MediApu Oy
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
BRIEF-Abbott announces CE Mark for i-STAT Alinity
* Abbott announces CE Mark for i-STAT Alinity, a handheld
blood testing platform
Source text for Eikon:
Further company coverage:
Read more
blood testing platform
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Austar Lifesciences Group issues profit warning
* Group is expected to incur a loss attributable to
shareholders of company for year ending 31 December 2016
Read more
shareholders of company for year ending 31 December 2016
Read more
BRIEF-Lepu Medical Technology Beijing issues 2016 1st tranche mid-term bills of 600 mln yuan
* Says it completed issuing 2016 1st tranche mid-term bills
of 600 million yuan with a term of three years on Nov. 28
Read more
of 600 million yuan with a term of three years on Nov. 28
Read more
BRIEF-Innate Pharma reports first clinical data for monalizumab
* First clinical data for monalizumab as a single agent in cancer patients show favorable
safety profile
Read more
safety profile
Read more
BRIEF-LabGenomics to issue second convertible bonds worth 10 bln won
* Says it will issue second unregistered and unsecured
private convertible bonds, to raise 10 billion won in proceeds
for operations
Read more
private convertible bonds, to raise 10 billion won in proceeds
for operations
Read more
BRIEF-Shandong Jincheng Pharma gets approval for asset acquisition plan, share trade to resume
* Says it gets securities regulator's approval for asset
acquisition plan, share trade to resume on Dec 1
Read more
acquisition plan, share trade to resume on Dec 1
Read more
German stocks - Factors to watch on November 30
FRANKFURT, Nov 30 (Reuters) - The DAX top-30 index
looked set to open 0.1 higher on Wednesday, according to
premarket data from brokerage Lang & Schwarz at 0708 GMT.
Read more
looked set to open 0.1 higher on Wednesday, according to
premarket data from brokerage Lang & Schwarz at 0708 GMT.
Read more
BRIEF-Bb Healthcare Trust raises 150 mln stg via placing
* It has successfully raised gross proceeds of 150 million
stg pursuant to first placing of ordinary shares of £0.01 each
Read more
stg pursuant to first placing of ordinary shares of £0.01 each
Read more
Tuesday, November 29, 2016
BRIEF-Evotec, Merck to collaborate on target discovery technologies
* Evotec and Merck enter into agreements to collaborate on
target discovery technologies
Source text for Eikon:
Further company coverage:
Read more
target discovery technologies
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Medipost receives patent
* Says it received China patent on Nov. 29, for composition
for the diagnosis, prevention or treatment of disease related to
cells expressing IL-8 or GRO-alpha, comprising UCB-MSCs
Read more
for the diagnosis, prevention or treatment of disease related to
cells expressing IL-8 or GRO-alpha, comprising UCB-MSCs
Read more
惠譽：中國藥品批發商的利潤率壓力與整合
(The following statement was released by the rating agency)
Link to Fitch Ratings' Report: China Pharmaceutical Distributors and Retail
Pharmacies Blue Book
https://www.fitchratings.com/site/re/888932
SHANGHAI, November 29 (Fitch) 本文章英文原文最初於2016年11月23日發布于：<a
href="https://www.fitchratings.com/site/pr/1015292">Fitch: Margin Pressure and
Consolidation for China's Pharma Distributors
惠譽評級表示，競爭日益激烈、監管更加嚴格和藥品價格降低將會對中國藥品批發商的利潤率帶來壓力，而勞動力和租金成本的不斷上升也將限制零售藥店的盈利能力，促進高度分散
的藥品流通行業進一步整合，而這將有利於大型藥品批
Read more
Link to Fitch Ratings' Report: China Pharmaceutical Distributors and Retail
Pharmacies Blue Book
https://www.fitchratings.com/site/re/888932
SHANGHAI, November 29 (Fitch) 本文章英文原文最初於2016年11月23日發布于：<a
href="https://www.fitchratings.com/site/pr/1015292">Fitch: Margin Pressure and
Consolidation for China's Pharma Distributors
惠譽評級表示，競爭日益激烈、監管更加嚴格和藥品價格降低將會對中國藥品批發商的利潤率帶來壓力，而勞動力和租金成本的不斷上升也將限制零售藥店的盈利能力，促進高度分散
的藥品流通行業進一步整合，而這將有利於大型藥品批
Read more
BRIEF-Actinogen Medical confirms retirement of chairman Martin Rogers
* Jason Loveridge will function as interim chairman
Source text for Eikon:
Further company coverage:
Read more
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Anteo Diagnostics appoints John Hurrell as non-exec chairman of Group
* Appointment of John Hurrell as non- executive chairman of
Anteo Group
Source text for Eikon:
Further company coverage:
Read more
Anteo Group
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Aurora Spine Corp qtrly loss per share $0.02
* Aurora Spine Corp - Revenues during quarter were in amount
of $1.6 million, representing a 39% increase
Source text for Eikon:
Further company coverage:
Read more
of $1.6 million, representing a 39% increase
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Newlink Genetics Corp says it entered into a controlled equity offering(SM)sales agreement with Cantor Fitzgerald & Co
* Newlink Genetics Corp says on Nov 29, 2016 co entered into
a controlled equity offering(SM)sales agreement with Cantor
Fitzgerald & Co-SEC filing
Read more
a controlled equity offering(SM)sales agreement with Cantor
Fitzgerald & Co-SEC filing
Read more
Novo Nordisk says Tresiba insulin achieves target in DEVOTE study
COPENHAGEN, Nov 29 (Reuters) - Novo Nordisk's
long-acting insulin blockbuster Tresiba has a safe
cardiovascular profile in patients with type 2 diabetes, results
released by the company on Tuesday showed.
Read more
long-acting insulin blockbuster Tresiba has a safe
cardiovascular profile in patients with type 2 diabetes, results
released by the company on Tuesday showed.
Read more
UPDATE 1-Novo Nordisk reports Tresiba insulin achieves target in study
COPENHAGEN, Nov 29 (Reuters) - Novo Nordisk's
long-acting insulin blockbuster Tresiba has a safe
cardiovascular profile and reduces episodes of severely low
blood glucose levels in patients with type 2 diabetes, the
Denmark-based company said on Tuesday.
Read more
long-acting insulin blockbuster Tresiba has a safe
cardiovascular profile and reduces episodes of severely low
blood glucose levels in patients with type 2 diabetes, the
Denmark-based company said on Tuesday.
Read more
BRIEF-Novo Nordisk says Tresiba demonstrates safe cardiovascular profile
* Says Tresiba demonstrates a safe cardiovascular profile
and reduces the risk of severe hypoglycaemia compared to insulin
glargine u100 in the devote trial
Read more
and reduces the risk of severe hypoglycaemia compared to insulin
glargine u100 in the devote trial
Read more
BRIEF-Invesco Ltd reports 33.47 pct stake in Motif Bio
* Invesco Ltd reports 33.47 pct stake in Motif Bio Plc
as of Nov 23 - SEC filing
Source text: (http://bit.ly/2g2v9zR)
Further company coverage:
Read more
as of Nov 23 - SEC filing
Source text: (http://bit.ly/2g2v9zR)
Further company coverage:
Read more
UPDATE 1-TDC loses major contract with Novo Nordisk to Telenor
COPENHAGEN, Nov 29 (Reuters) - Danish telecoms group TDC
has lost a major contract in Denmark after one of the
country's biggest employers, Novo Nordisk, said it
chose Norway's Telenor as its telecoms supplier.
Read more
has lost a major contract in Denmark after one of the
country's biggest employers, Novo Nordisk, said it
chose Norway's Telenor as its telecoms supplier.
Read more
BRIEF-Celon Pharma 9-month net profit up at 35.1 mln zlotys yoy
* 9-Month revenue 81.2 million zlotys ($19.42 million)
versus 77.5 million zlotys a year ago
Read more
versus 77.5 million zlotys a year ago
Read more
BRIEF-ARIAD announces FDA full approval and label update for Iclusig (ponatinib)
* ARIAD announces FDA full approval and label update for
Iclusig (ponatinib) based on long-term efficacy and safety data
from Phase 2 PACE clinical trial
Read more
Iclusig (ponatinib) based on long-term efficacy and safety data
from Phase 2 PACE clinical trial
Read more
BRIEF-Braster allots 105,000 series A bonds
* Allots 105,000 series A bonds of total nominal value of
10.5 million zlotys ($2.51 million) at reduction rate of 27.65
percent
Read more
10.5 million zlotys ($2.51 million) at reduction rate of 27.65
percent
Read more
BRIEF-Depuy Synthes says new UK joint registry data confirms positive early results for Depuy Synthes Attune Knee system
* New UK joint registry data confirms positive early results
for the Depuy Synthes Attune Knee system
Source text for Eikon:
Further company coverage:
Read more
for the Depuy Synthes Attune Knee system
Source text for Eikon:
Further company coverage:
Read more
Momenta's Humira biosimilar succeeds in key psoriasis study
Nov 29 (Reuters) - U.S. biotech company Momenta
Pharmaceuticals Inc said on Tuesday its experimental
biosimilar version of AbbVie Inc's top-selling
autoimmune drug, Humira, met the main goal in a late-stage trial
involving patients with a form of psoriasis.
Read more
Pharmaceuticals Inc said on Tuesday its experimental
biosimilar version of AbbVie Inc's top-selling
autoimmune drug, Humira, met the main goal in a late-stage trial
involving patients with a form of psoriasis.
Read more
BRIEF-AMRI announces API agreement supply with Shire
* Has entered into a multi-year supply agreement for an
undisclosed product with shire us manufacturing
Source text for Eikon:
Further company coverage:
Read more
undisclosed product with shire us manufacturing
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Medimmune and Abpro enter into a collaborative agreement
* Press release - Medimmune and Abpro enter into a
collaborative agreement for a novel bispecific antibody
Source text for Eikon:
Read more
collaborative agreement for a novel bispecific antibody
Source text for Eikon:
Read more
UPDATE 2-Trump looks to Obamacare critic to overhaul healthcare
NEW YORK, Nov 29 (Reuters) - President-elect Donald Trump on
Tuesday named a vociferous Obamacare critic and an Indiana
policy consultant to help him overhaul the U.S. healthcare
system.
Read more
Tuesday named a vociferous Obamacare critic and an Indiana
policy consultant to help him overhaul the U.S. healthcare
system.
Read more
BRIEF-Orasure technologies says it will start a contract to supply a foreign government
* Says it will begin fulfilling a contract to supply a
foreign government with $18 million of product
Read more
foreign government with $18 million of product
Read more
BRIEF-Combimatrix's pre-implantation genetic screening granted conditional approval
* combimatrix's pre-implantation genetic screening by next
generation sequencing granted conditional approval from New York
state department of health
Read more
generation sequencing granted conditional approval from New York
state department of health
Read more
BRIEF-Biofrontera: European Commission provides unlimited approval for Ameluz
* European Commission provides unlimited approval for Ameluz
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
BRIEF-Ewa Kruk buys 200,000 shares of Biogened via private subscription
* Said on Monday that Ewa Kruk bought 200,000 series I
shares at the issue price 15 zlotys per share via private
subscription
Read more
shares at the issue price 15 zlotys per share via private
subscription
Read more
Monday, November 28, 2016
BRIEF-Medinova Diagnostic Services approves equity issue to Vijaya Diagnostic Centre
* Says approved issue of 500,000 equity shares to Vijaya
Diagnostic Centre Private Limited
Source text: http://bit.ly/2fww679
Further company coverage:
Read more
Diagnostic Centre Private Limited
Source text: http://bit.ly/2fww679
Further company coverage:
Read more
Swiss stocks - Factors to watch on Nov.29
ZURICH, Nov 29 (Reuters) - The following are some of the
main factors expected to affect Swiss stocks on Tuesday.
Read more
main factors expected to affect Swiss stocks on Tuesday.
Read more
BRIEF-Easywell Biomedical unit completes pilot SAD pharmacokinetic clinical study of parkinson treatment
* Says its 50.2-percent-owned unit completed pilot SAD
pharmacokinetic clinical study of parkinson treatment in
Malaysia
Read more
pharmacokinetic clinical study of parkinson treatment in
Malaysia
Read more
UPDATE 6-Trump to name Georgia lawmaker Tom Price as health secretary pick
NEW YORK, Nov 28 (Reuters) - President-elect Donald Trump is
set to announce on Tuesday that he has chosen Republican U.S.
Representative Tom Price, an orthopedic surgeon and vociferous
critic of the Affordable Care Act, as health and human services
secretary, two sources told Reuters.
Read more
set to announce on Tuesday that he has chosen Republican U.S.
Representative Tom Price, an orthopedic surgeon and vociferous
critic of the Affordable Care Act, as health and human services
secretary, two sources told Reuters.
Read more
惠譽：中國製藥行業：仿製藥主導的市場，具有良好增長前景
(The following statement was released by the rating agency)
SHANGHAI, November 28 (Fitch) 本文章英文原文最初於2016年11月23日發布于：<a
href="https://www.fitchratings.com/site/pr/1015293">Fitch: China Pharma
Manufacturers: Healthy Growth as Generics Dominate
惠譽評級預計在中期內，中國的醫院和零售藥店的藥品銷售將繼續保持健康的增長。這一增長勢頭的支持因素包括老齡化人口的醫療需求上升、城市化持續進行、可支配收入上升、醫
療保險覆蓋範圍擴大、以及公眾更容易獲得治療與醫療設施。
然而，惠譽的增長展望顯示，未來行業的增速與2007-2012年期間超過20%的同比增長率峰值相比將出現小幅放緩，這是因為國家醫療保險的費用控制、由藥品招標導致的
藥品價格降低、以及政府醫療開支的增長放緩。
仿製藥主導著中國的醫藥市場，在藥品銷售總額中占85%的份額。中國製藥商的
Read more
SHANGHAI, November 28 (Fitch) 本文章英文原文最初於2016年11月23日發布于：<a
href="https://www.fitchratings.com/site/pr/1015293">Fitch: China Pharma
Manufacturers: Healthy Growth as Generics Dominate
惠譽評級預計在中期內，中國的醫院和零售藥店的藥品銷售將繼續保持健康的增長。這一增長勢頭的支持因素包括老齡化人口的醫療需求上升、城市化持續進行、可支配收入上升、醫
療保險覆蓋範圍擴大、以及公眾更容易獲得治療與醫療設施。
然而，惠譽的增長展望顯示，未來行業的增速與2007-2012年期間超過20%的同比增長率峰值相比將出現小幅放緩，這是因為國家醫療保險的費用控制、由藥品招標導致的
藥品價格降低、以及政府醫療開支的增長放緩。
仿製藥主導著中國的醫藥市場，在藥品銷售總額中占85%的份額。中國製藥商的
Read more
PRESS DIGEST- Financial Times - Nov 29
Nov 29 (Reuters) - The following are the top stories in the
Financial Times. Reuters has not verified these stories and does
not vouch for their accuracy.
Read more
Financial Times. Reuters has not verified these stories and does
not vouch for their accuracy.
Read more
BRIEF-Northeast Tiger Pharmaceutical announces resignation of CFO
* Jiang Min Yu has resigned as chief financial officer of
company with effect from 28 november 2016
Read more
company with effect from 28 november 2016
Read more
BRIEF-Nuvasive repurchased about $49.6 mln in aggregate principal amount of its 2.75 PCT convertible senior notes due 2017
* Nuvasive-From Nov 11 to nov 28, repurchased about $49.6
million in aggregate principal amount of its 2.75% convertible
senior notes due 2017 - SEC filing
Read more
million in aggregate principal amount of its 2.75% convertible
senior notes due 2017 - SEC filing
Read more
BRIEF-Windtree Therapeutics says presented Aerosurf Phase 2A data
* Windtree Therapeutics' Aerosurf (lucinactant for
inhalation) phase 2A data presented at the 2016 International
Congress of Union of European Neonatal and Perinatal Societies
Source text for Eikon:
Further company coverage:
Read more
inhalation) phase 2A data presented at the 2016 International
Congress of Union of European Neonatal and Perinatal Societies
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Camber Capital Management reports 5.53 pct passive stake in Myriad Genetics
* Camber Capital Management LLC reports 5.53 percent passive
stake in Myriad Genetics Inc as of November 16 - sec filing
Source text : http://bit.ly/2fuddBZ
Further company coverage:
Read more
stake in Myriad Genetics Inc as of November 16 - sec filing
Source text : http://bit.ly/2fuddBZ
Further company coverage:
Read more
BRIEF-Theraclion announces installation of echotherapy system in UK
* Theraclion announces commercial agreement for installation of first echotherapy system in
UK dedicated to treatment of thyroid nodules
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
UK dedicated to treatment of thyroid nodules
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
BRIEF-Opaleye Management's Silverman reports 5.26 pct passive stake in Wafergen Bio-systems
* Opaleye Management Inc's James Silverman reports 5.26 Pct
Passive Stake In Wafergen Bio-systems Inc as of Nov 17
- SEC filing
Source text: (http://bit.ly/2gA8oD3)
Further company coverage:
Read more
Passive Stake In Wafergen Bio-systems Inc as of Nov 17
- SEC filing
Source text: (http://bit.ly/2gA8oD3)
Further company coverage:
Read more
CORRECTED-OFFICIAL-BRIEF-Kontigo Care Q3 EBITDA loss slightly widens to SEK 3.2 million
* Q3 EBITDA loss 3.2 million Swedish crowns ($347,245) versus loss 3.1 million crowns year
ago
Read more
ago
Read more
BRIEF-Nexstim issues 4.1 million new shares to Bracknor
* Issues shares in standby equity distribution agreement pursuant to the financing
arrangement announced on July 21, 2016
Read more
arrangement announced on July 21, 2016
Read more
BRIEF-Gilead Capital says it is dismayed that Executive Chairman remains on Landauers board
* Gilead Capital says it is dismayed that Executive Chairman
Michael Leatherman remains on Landauers board and that board
intends to nominate him for re-election as a director
Read more
Michael Leatherman remains on Landauers board and that board
intends to nominate him for re-election as a director
Read more
BRIEF-Mylan signs sub-license agreement with the Medicines Patent Pool to produce and market DAKLINZA tablets to 112 countries
* Mylan signs sub-license agreement with the Medicines
Patent Pool to increase access to Hepatitis C treatment in
developing countries
Read more
Patent Pool to increase access to Hepatitis C treatment in
developing countries
Read more
BRIEF-Global Blood Therapeutics to initiate mid-stage trial for the treatment of idiopathic pulmonary fibrosis
* Global Blood Therapeutics announces initiation of phase 2a
trial of GBT440 in idiopathic pulmonary fibrosis (IPF)
Read more
trial of GBT440 in idiopathic pulmonary fibrosis (IPF)
Read more
BRIEF-Nature Cell receives FDA approval for early and mid-stage alzheimer's clinical trial
* Nature Cell Co Ltd receives U.S. FDA approval for phase I
and II alzheimer's clinical trial
Read more
and II alzheimer's clinical trial
Read more
BRIEF-Recro Pharma reports positive top-line results
* Recro pharma reports positive top-line results from
pivotal Phase III clinical trial of IV meloxicam
Read more
pivotal Phase III clinical trial of IV meloxicam
Read more
BRIEF-Lanhai Medical Investment's shares to halt trading from Nov 29 pending announcement
* Says shares to halt trading from November 29 pending
announcement related to asset restructuring
Read more
announcement related to asset restructuring
Read more
Deals of the day-Mergers and acquisitions
Nov 28 (Reuters) - The following bids, mergers, acquisitions
and disposals were reported by 1115 GMT on Monday:
Read more
and disposals were reported by 1115 GMT on Monday:
Read more
BRIEF-Medivir says Janssen initiates a phase IIb study
* Says a phase IIb open-label study of the combination of
simeprevir, odalasvir and AL-335, also known as JNJ-4178, has
been initiated by Janssen Research & Development
Read more
simeprevir, odalasvir and AL-335, also known as JNJ-4178, has
been initiated by Janssen Research & Development
Read more
BRIEF-Kontigo Care appoints Jonas Saric new CFO
* Appoints Jonas Saric new CFO
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
Sunday, November 27, 2016
BRIEF-Capitol Health appoints James Harkness as CFO
* Appointment of James Harkness as chief financial officer
Source text for Eikon:
Further company coverage:
Read more
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Addex Therapeutics appoints Roger G. Mills as Chief Medical Officer
* Says Addex appoints biopharmaceutical industry veteran,
Roger G. Mills, M.D., as Chief Medical Officer
Source text - http://bit.ly/2gNzjj5
Further company coverage:
(Gdynia Newsroom)
Read more
Roger G. Mills, M.D., as Chief Medical Officer
Source text - http://bit.ly/2gNzjj5
Further company coverage:
(Gdynia Newsroom)
Read more
Swiss stocks - Factors to watch on Nov 28
ZURICH, Nov 28 (Reuters) - Here are some of the main factors
that may affect Swiss stocks on Monday:
Read more
that may affect Swiss stocks on Monday:
Read more
BRIEF-Uscom awarded Euro grant for lung cancer diagnostic
* Notified that Uscom was a member of a consortium awarded
2.2mln euro over 3 years to develop a new exhaled breath
condensate device
Source text for Eikon:
Further company coverage:
Read more
2.2mln euro over 3 years to develop a new exhaled breath
condensate device
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Probiotec Ltd says Geoffrey Ronald Pearce has been appointed as company's Chairman
* Geoffrey Ronald Pearce has joined company's board as an
independent, Non-Executive Director and has been appointed as
company's Chairman
Read more
independent, Non-Executive Director and has been appointed as
company's Chairman
Read more
Baker Hughes shares set to rise on GE deal -Barron's
NEW YORK, Nov 27 (Reuters) - Shares of oilfield services
company Baker Hughes Inc could rise significantly if it
completes its merger with General Electric Co's oil and
gas division, according to a report in Barron's.
Read more
company Baker Hughes Inc could rise significantly if it
completes its merger with General Electric Co's oil and
gas division, according to a report in Barron's.
Read more
Dutch destroy 190,000 ducks in first bird flu cull
AMSTERDAM, Nov 26 (Reuters) - Some 190,000 ducks were
destroyed on Saturday at six farms in the Netherlands following
an avian flu outbreak, the country's first cull of an epidemic
sweeping northern Europe.
Read more
destroyed on Saturday at six farms in the Netherlands following
an avian flu outbreak, the country's first cull of an epidemic
sweeping northern Europe.
Read more
Saturday, November 26, 2016
BRIEF-Theratechnologies announces filing of final short form prospectus
* Theratechnologies announces the filing of a final short
form prospectus
Source text for Eikon:
Further company coverage:
Read more
form prospectus
Source text for Eikon:
Further company coverage:
Read more
Friday, November 25, 2016
BRIEF-Dilon Diagnostics and GE Healthcare announce FDA clearance of Discovery NM 750B biopsy accessory
* Dilon Diagnostics and GE Healthcare announce the FDA
clearance of the discovery NM 750B biopsy accessory
Source text for Eikon:
Read more
clearance of the discovery NM 750B biopsy accessory
Source text for Eikon:
Read more
REFILE-US STOCKS-Wall St hit record highs as consumer staples, techs gain
Nov 25 (Reuters) - Wall Street extended its gains in thin
trading on Friday, with the three main indexes hitting record
intraday highs, helped by gains in consumer staples and
technology stocks.
Read more
trading on Friday, with the three main indexes hitting record
intraday highs, helped by gains in consumer staples and
technology stocks.
Read more
BRIEF-DASA to buy three companies in Sao Jose dos Campos
* Said on Thursday that its board of directors approved to
buy 100 percent of the companies Biomed Diagnosticos
Laboratoriais Ltda, Laboratorio Oswaldo Cruz Ltda and Sawaya &
Giana Servicos Auxiliares de Organizacao de Escritorios Ltda
Read more
buy 100 percent of the companies Biomed Diagnosticos
Laboratoriais Ltda, Laboratorio Oswaldo Cruz Ltda and Sawaya &
Giana Servicos Auxiliares de Organizacao de Escritorios Ltda
Read more
Fitch Affirms Derby Healthcare's GBP446.6m Bonds at 'BBB'; Outlook Stable
(The following statement was released by the rating agency)
LONDON, November 25 (Fitch) Fitch Ratings has affirmed Derby
Healthcare PLC's
(DHC) GBP446.6m bonds, maturing in 2041, at 'BBB'. The Outlook
is Stable.
The rating primarily reflects stable availability-based revenues
from a
creditworthy counterparty and low cost risk due to pass-through
to contractors.
The project's stability is evidenced by robust operational
performance with
minimum deductions and strong relationship shown between
Read more
LONDON, November 25 (Fitch) Fitch Ratings has affirmed Derby
Healthcare PLC's
(DHC) GBP446.6m bonds, maturing in 2041, at 'BBB'. The Outlook
is Stable.
The rating primarily reflects stable availability-based revenues
from a
creditworthy counterparty and low cost risk due to pass-through
to contractors.
The project's stability is evidenced by robust operational
performance with
minimum deductions and strong relationship shown between
Read more
Finland confirms H5N8 bird flu found in Aland islands
HELSINKI, Nov 25 (Reuters) - The first confirmed case of
H5N8 bird flu has been detected in Finland amid a recent
outbreak of the disease in Europe, the Finnish Food Safety
authority said on Friday.
Read more
H5N8 bird flu has been detected in Finland amid a recent
outbreak of the disease in Europe, the Finnish Food Safety
authority said on Friday.
Read more
Actelion confirms Johnson & Johnson approach
ZURICH, Nov 25 (Reuters) - Actelion has confirmed
it has been approached by Johnson & Johnson about a
possible transaction to take over the Swiss drugmaker.
Read more
it has been approached by Johnson & Johnson about a
possible transaction to take over the Swiss drugmaker.
Read more
Multi-nationals overcome Brexit strains to boost FTSE earnings
LONDON, Nov 25 (Reuters) - Major companies listed in London
overcame the shock of Brexit to report robust third quarter
trading, with strong performances from multi-national firms
helping to offset domestic pressure and lift overall forecasts.
Read more
overcame the shock of Brexit to report robust third quarter
trading, with strong performances from multi-national firms
helping to offset domestic pressure and lift overall forecasts.
Read more
BRIEF-Can-Fite reports results for nine months ended Sept. 30
* Can-Fite reports financial results for nine months ended
September 30, 2016 & provides clinical update
Read more
September 30, 2016 & provides clinical update
Read more
BRIEF-Opexa Therapeutics receives notice from Ares Trading S.A. Unit of Merck Serono
* Opexa Therapeutics - On Nov 23, co received notice from
Ares Trading S.A. Unit of Merck Serono
Read more
Ares Trading S.A. Unit of Merck Serono
Read more
BRIEF-Intellipharmaceutics submits new drug application for Rexista
* Intellipharmaceutics submits new drug application for
Rexista (oxycodone hydrochloride extended release), an abuse
deterrent opioid analgesic for the treatment of moderate to
severe pain
Read more
Rexista (oxycodone hydrochloride extended release), an abuse
deterrent opioid analgesic for the treatment of moderate to
severe pain
Read more
BRIEF-CollPlant sees U.S. IPO of 3.5 mln ADSs
* CollPlant Holdings Ltd sees U.S. IPO of 3.5 million
American Depositary Shares - SEC filing
Source text: (http://bit.ly/2gneoPr)
Further company coverage:
Read more
American Depositary Shares - SEC filing
Source text: (http://bit.ly/2gneoPr)
Further company coverage:
Read more
BRIEF-Shenzhen Neptunus Bioengineering to set up investment JV with CITIC Securities
* Says it plans to set up investment JV with size up to 1.5
billion yuan ($216.86 million) with CITIC Securities Co Ltd
Read more
billion yuan ($216.86 million) with CITIC Securities Co Ltd
Read more
Deals of the day-Mergers and acquisitions
Nov 25 (Reuters) - The following bids, mergers, acquisitions
and disposals were reported by 1100 GMT on Friday:
Read more
and disposals were reported by 1100 GMT on Friday:
Read more
BRIEF-Kangmei Pharmaceutical issues debentures worth 2 bln yuan
* Says it issued 2016 second tranche super short-term
debentures worth 2 billion yuan with a term of 270 days and
interest rate of 3.5 percent
Read more
debentures worth 2 billion yuan with a term of 270 days and
interest rate of 3.5 percent
Read more
BRIEF-Jubilant Life Sciences seeks members' nod for issue of NCDs worth up to 10 bln rupees
* Seeks members' nod for issue of non-convertible debentures
worth up to 10 billion rupees
Source text: http://bit.ly/2gmAC4b
Further company coverage:
Read more
worth up to 10 billion rupees
Source text: http://bit.ly/2gmAC4b
Further company coverage:
Read more
Thursday, November 24, 2016
BRIEF-Brighter 9-month operating income up at SEK 17.1 mln
* 9-Month operating income 17.1 million Swedish crowns
($1.85 million) versus 9.3 million crowns year ago
Read more
($1.85 million) versus 9.3 million crowns year ago
Read more
BRIEF-Consort Medical names Vitec finance head Paul Hayes as its next CFO
* Paul Hayes, finance director of Vitec Group Plc, is to
succeed Richard Cotton as Consort Medical's group chief
financial officer
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +91 806 749 1136)
Read more
succeed Richard Cotton as Consort Medical's group chief
financial officer
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +91 806 749 1136)
Read more
BRIEF-China Grand Automotive Services' affiliated firm establishes auto investment management JV
* Says its affiliated company and partner invested 6.6
billion yuan and established auto investment management firm
Read more
billion yuan and established auto investment management firm
Read more
BRIEF-Dottikon H1 net income up at around CHF 9.5 mln
* H1 net income rose to around 9.5 million Swiss francs
($9.35 million)(previous year: 1.0 million Swiss francs)
Read more
($9.35 million)(previous year: 1.0 million Swiss francs)
Read more
BRIEF-Opto Circuits (India) posts loss in Sept quarter
* Consol net profit in sept quarter last year was 621.4
million rupees; consol net sales was 781 million rupees
Source text: http://bit.ly/2fXhUDf
Further company coverage:
Read more
million rupees; consol net sales was 781 million rupees
Source text: http://bit.ly/2fXhUDf
Further company coverage:
Read more
BRIEF-Shenyang Xingqi Pharmaceutical sets pricing for Shenzhen IPO
* Says it plans to issue up to 20 million shares at 5.16
yuan per share to raise up to 103.3 million yuan ($14.94
million) for its Shenzhen IPO
Read more
yuan per share to raise up to 103.3 million yuan ($14.94
million) for its Shenzhen IPO
Read more
Costly leukaemia pill wins UK green light after price cut
LONDON, Nov 25 (Reuters) - A costly blood cancer pill sold
in Europe by Johnson & Johnson will be made routinely
available to certain patients in Britain with chronic
lymphocytic leukaemia, after the U.S. company agreed to cut the
price.
Read more
in Europe by Johnson & Johnson will be made routinely
available to certain patients in Britain with chronic
lymphocytic leukaemia, after the U.S. company agreed to cut the
price.
Read more
BRIEF-Abano Healthcare updates on takeover notice from Healthcare Partners
* Refers to takeover notice dated 24 November 2016 from
Healthcare Partners Holdings Limited
Read more
Healthcare Partners Holdings Limited
Read more
BRIEF-Shark Mitigation Systems requests trading halt
* Requests trading halt pending announcement regarding
transaction involving co's Clever Buoy Technology
Read more
transaction involving co's Clever Buoy Technology
Read more
BRIEF-Healthcare Partners offers to acquire 30.99 pct of Abano Healthcare for NZ$10 per share
* offering to acquire 30.99% of fully paid ordinary shares
in Abano Healthcare Group at offer price of nz$10 per
share in cash
Source text for Eikon:
Further company coverage:
Read more
in Abano Healthcare Group at offer price of nz$10 per
share in cash
Source text for Eikon:
Further company coverage:
Read more
UPDATE 1-J&J makes takeover approach for Swiss drugmaker Actelion -Bloomberg
Nov 24 (Reuters) - U.S. healthcare company Johnson & Johnson
has approached Swiss biotechnology firm Actelion Ltd
about a potential takeover, Bloomberg reported on
Thursday, citing people it said were familiar with the matter.
Read more
has approached Swiss biotechnology firm Actelion Ltd
about a potential takeover, Bloomberg reported on
Thursday, citing people it said were familiar with the matter.
Read more
BRIEF-Chinese carmaker Geely has denied being one of a few foreign companies considering a stake in Malaysia's Proton Holdings -Nikkei
* Chinese carmaker Geely has denied being one of a few
foreign companies considering a stake in Malaysia's Proton
Holdings -Nikkei
Source text for Eikon:
Further company coverage:
Read more
foreign companies considering a stake in Malaysia's Proton
Holdings -Nikkei
Source text for Eikon:
Further company coverage:
Read more
J&J makes takeover approach for Swiss drugmaker Actelion -Bloomberg
Nov 24 (Reuters) - U.S. healthcare company Johnson & Johnson
has approached Swiss biotechnology firm Actelion Ltd
about a potential takeover, Bloomberg reported on
Thursday, citing people it said were familiar with the matter.
Read more
has approached Swiss biotechnology firm Actelion Ltd
about a potential takeover, Bloomberg reported on
Thursday, citing people it said were familiar with the matter.
Read more
BRIEF-Sensorion receives Orphan Drug Designation in Europe for SENS-401
* Receives Orphan Drug Designation in Europe for SENS-401 in
sudden sensorineural hearing loss
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
sudden sensorineural hearing loss
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
EU mergers and takeovers (Nov 24)
BRUSSELS, Nov 24 (Reuters) - The following are mergers under
review by the European Commission and a brief guide to the EU
merger process:
Read more
review by the European Commission and a brief guide to the EU
merger process:
Read more
Dengue fever outbreak kills 18 in Burkina Faso - charity
DAKAR, Nov 24 (Thomson Reuters Foundation) - Dengue fever
has killed at least 18 people in Burkina Faso since August in
the worst recorded outbreak of the disease to hit the West
African nation, an aid agency said on Thursday.
Read more
has killed at least 18 people in Burkina Faso since August in
the worst recorded outbreak of the disease to hit the West
African nation, an aid agency said on Thursday.
Read more
BRIEF-Atrys Health wins EU grant to develop anti-tumor drug
* Says wins 0.6 million euros ($634,380) non-refundable
European Union grant for Therayap project to develop anti-tumor
drug
Read more
European Union grant for Therayap project to develop anti-tumor
drug
Read more
Scientists say gut microbes may play role in yo-yo dieting, obesity
LONDON, Nov 24 (Reuters) - Scientists studying yo-yo dieting
in mice say the tendency for people to regain excess weight
rapidly after successfully slimming may well be due to their
microbiome - the trillions of microorganisms in the gut.
Read more
in mice say the tendency for people to regain excess weight
rapidly after successfully slimming may well be due to their
microbiome - the trillions of microorganisms in the gut.
Read more
BRIEF-Biogened to raise up to 5 mln zlotys through series BGD1119 bonds
* Resolves to issue no more than 5,000 series BGD1119 bonds
at the issue price of 1,000 zlotys ($239.12) each
Read more
at the issue price of 1,000 zlotys ($239.12) each
Read more
BRIEF-ITC Properties' unit to subscribe for loan notes
* Advance Tech (an indirect wholly-owned subsidiary of
company) accepted subscription letter from placing agent
Read more
company) accepted subscription letter from placing agent
Read more
BRIEF-VibroSense gets SEK 0.8 mln in research grant, updates on financial target
* Says Vinnova decided to allocate VibroSense additional about 0.8 million
crowns as research grant
Read more
crowns as research grant
Read more
BRIEF-LifeAssays announces new partner for Lithuania, gets order of EUR 3,450
* Signs Letter of Intent with Interlux for marketing and sales of LifeAssays products in
Lithuania
Read more
Lithuania
Read more
West Africa tackles human and animal health together to contain diseases
DAKAR, Nov 24 (Thomson Reuters Foundation) - A drive by West
African nations to tackle zoonotic diseases, those that jump
from animals to humans, could help to protect the region from
future health crises such as the world's worst Ebola outbreak, a
United Nations official said on Thursday.
Read more
African nations to tackle zoonotic diseases, those that jump
from animals to humans, could help to protect the region from
future health crises such as the world's worst Ebola outbreak, a
United Nations official said on Thursday.
Read more
BRIEF-Neuron Bio to issue 3.7 million euros in new shares to finance Neol delisting
* Says to issue 3.7 million euros ($3.91 million) in new
shares to Neol shareholders at 2.42 euros per share
Read more
shares to Neol shareholders at 2.42 euros per share
Read more
BRIEF-Hunan Hansen Pharma's major shareholder to reduce shares in the company
* Says major shareholder plans to reduce up to 29.5 million
shares in the company in next six months
Read more
shares in the company in next six months
Read more
BRIEF-IHH Healthcare Bhd says qtrly revenue 2.44 billion rgt versus 2.06 billion rgt
* Qtrly net profit 173.3 million rgt versus 118.5 million
rgt
Source text (http://bit.ly/2fujjAt)
Further company coverage:
Read more
rgt
Source text (http://bit.ly/2fujjAt)
Further company coverage:
Read more
BRIEF-Pharmstandard shares to be excluded from indices of Moscow Stock Exchange
* In connection with the suspension of trading Pharmstandard
shares to be excluded from indices of Moscow Stock
Exchange as of Nov. 29
Source text - http://bit.ly/2fa9g55
Read more
shares to be excluded from indices of Moscow Stock
Exchange as of Nov. 29
Source text - http://bit.ly/2fa9g55
Read more
BRIEF-Bionor Pharma private placement successfully completed
* Will receive gross proceeds of 150 million Norwegian crowns ($17.38 million) from private
placement when completed
Read more
placement when completed
Read more
BRIEF-Argan Capital sells 6 mln shares in Humana
* Says Argan Capital through Air Syndication Sca (Argan Capital), has sold 6
million shares in Humana AB (publ) through accelerated bookbuilding
to Swedish and international investors at price of 74.00 Swedish crowns per
share
Read more
million shares in Humana AB (publ) through accelerated bookbuilding
to Swedish and international investors at price of 74.00 Swedish crowns per
share
Read more
Wednesday, November 23, 2016
BRIEF-UDG FY profit rises, sees future growth
* Fy diluted earnings per share 1 (eps) from continuing
operations increased by 8% (9% on a constant currency basis)
Read more
operations increased by 8% (9% on a constant currency basis)
Read more
MIDEAST STOCKS-Saudi may weaken on profit-booking but poised to end week up
DUBAI, Nov 24 (Reuters) - Saudi Arabian equities are likely
to pull back on Thursday as investors may choose to cash-out of
the recent strong rebound over the last two sessions while other
Gulf bourses are expected to consolidate.
Read more
to pull back on Thursday as investors may choose to cash-out of
the recent strong rebound over the last two sessions while other
Gulf bourses are expected to consolidate.
Read more
BRIEF-Shanghai Kaibao Pharmaceutical signs agreement to set up academician workstation
* Says it enters into a cooperation agreement with
academician Li Lianda, to set up academician workstation
focusing on research of co's projects
Read more
academician Li Lianda, to set up academician workstation
focusing on research of co's projects
Read more
Fitch: Margin Pressure and Consolidation for China's Pharma Distributors
(The following statement was released by the rating agency)
Link to Fitch Ratings' Report: China Pharmaceutical Distributors
and Retail
Pharmacies Blue Book
https://www.fitchratings.com/site/re/888932
SHANGHAI, November 23 (Fitch) Intensifying competition, stricter
regulations and
declining drug prices will pressure the margins of Chinese
pharmaceutical
distributors, while rising labour and rental costs will
constrain retail
pharmacy profitability, leading to further consolidation of the
hig
Read more
Link to Fitch Ratings' Report: China Pharmaceutical Distributors
and Retail
Pharmacies Blue Book
https://www.fitchratings.com/site/re/888932
SHANGHAI, November 23 (Fitch) Intensifying competition, stricter
regulations and
declining drug prices will pressure the margins of Chinese
pharmaceutical
distributors, while rising labour and rental costs will
constrain retail
pharmacy profitability, leading to further consolidation of the
hig
Read more
Fitch: China Pharma Manufacturers: Healthy Growth as Generics Dominate
(The following statement was released by the rating agency)
SHANGHAI, November 23 (Fitch) Fitch Ratings expects China's
pharmaceutical sales
through hospitals and retail pharmacies to maintain a healthy
growth over the
medium term. This momentum is underpinned by rising medical
demand from an
ageing population; continuing urbanisation; rising disposable
income; broadening
medical insurance coverage; and improving public access to
medical treatment and
facilities.
However, our growth outloo
Read more
SHANGHAI, November 23 (Fitch) Fitch Ratings expects China's
pharmaceutical sales
through hospitals and retail pharmacies to maintain a healthy
growth over the
medium term. This momentum is underpinned by rising medical
demand from an
ageing population; continuing urbanisation; rising disposable
income; broadening
medical insurance coverage; and improving public access to
medical treatment and
facilities.
However, our growth outloo
Read more
BRIEF-Living Cell Technologies Seeks trading halt
* Seeks a trading halt with immediate effect pending a
capital raising through hunter capital advisors
Read more
capital raising through hunter capital advisors
Read more
BRIEF-Patterson Companies entered into stock repurchase plan to repurchase up to $50 mln
* Patterson companies - entered into stock repurchase plan
to repurchase up to $50 million of co's common stock commencing
nov 25, 2016 through feb 15, 2017
Read more
to repurchase up to $50 million of co's common stock commencing
nov 25, 2016 through feb 15, 2017
Read more
U.S. Senate panel postpones Mylan hearing
WASHINGTON, Nov 23 (Reuters) - The U.S. Senate Judiciary
Committee on Monday postponed a hearing planned for next week to
discuss Mylan NV's pending $465 million settlement to
resolve charges that it underpaid government healthcare programs
by misclassifying its EpiPen emergency allergy treatment.
Read more
Committee on Monday postponed a hearing planned for next week to
discuss Mylan NV's pending $465 million settlement to
resolve charges that it underpaid government healthcare programs
by misclassifying its EpiPen emergency allergy treatment.
Read more
BRIEF-Cascadian Therapeutics announces stockholders and board of directors approve reverse stock split
* Cascadian Therapeutics announces stockholders and board of
directors approve reverse stock split
Source text for Eikon:
Further company coverage:
Read more
directors approve reverse stock split
Source text for Eikon:
Further company coverage:
Read more
Roche confident in Alzheimer's programmes, despite Lilly flop
ZURICH, Nov 23 (Reuters) - Roche said on Wednesday
it still believed drugs targeting a protein called beta amyloid
had potential to help fight Alzheimer's disease, despite the
high-profile failure of such a product from Eli Lilly.
Read more
it still believed drugs targeting a protein called beta amyloid
had potential to help fight Alzheimer's disease, despite the
high-profile failure of such a product from Eli Lilly.
Read more
BRIEF-Rosetta Genomics announces pricing of $5 million concurrent registered direct and private placement offering
* Entered into definitive agreements with one institutional
healthcare investor to purchase an aggregate of 1.1 million
ordinary shares
Read more
healthcare investor to purchase an aggregate of 1.1 million
ordinary shares
Read more
Scientists develop skin patch with on-the-spot sweat monitor app
LONDON, Nov 23 (Reuters) - Scientists in the United States
have developed a flexible microfluidic device that easily sticks
to the skin and measures sweat levels to show how the wearer's
body is responding to exercise.
Read more
have developed a flexible microfluidic device that easily sticks
to the skin and measures sweat levels to show how the wearer's
body is responding to exercise.
Read more
BRIEF-Amplitude Surgical Q1 sales raises to 17.3 million euros
* Q1 2016-17 sales of 17.3 million euros ($18.26 million), up 23.2 pct in actual terms and
21.4 pct at constant currency
Read more
21.4 pct at constant currency
Read more
BRIEF-Neovacs signs production partnership with 3P Biopharmaceuticals
* Neovacs signs production partnership with 3p biopharmaceuticals, a leading gmp producer of
biological drugs
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
biological drugs
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
EU regulator conditionally approves Abbott's purchase of St Jude
BRUSSELS, Nov 23 (Reuters) - The European Commission on
Wednesday said it has given its conditional approval to U.S.
medical device maker Abbott Laboratories' bid for peer
St Jude Medical Inc.
Read more
Wednesday said it has given its conditional approval to U.S.
medical device maker Abbott Laboratories' bid for peer
St Jude Medical Inc.
Read more
BRIEF-Biomaxima buys 80 percent of Qias Med and Istar
* Signs a deal to buy 80 percent of Romanian Qias Med and
Istar for 138,000 euros ($145,521) plus tax
Read more
Istar for 138,000 euros ($145,521) plus tax
Read more
Russia reported two outbreaks of severe H5 bird flu virus - OIE
PARIS, Nov 23 (Reuters) - Russia reported two outbreaks of
highly contagious bird flu virus among backyard birds in the
southwestern part of the country, the World Organisation for
Animal Health (OIE) said on Wednesday, citing a report from the
Russian farm ministry.
Read more
highly contagious bird flu virus among backyard birds in the
southwestern part of the country, the World Organisation for
Animal Health (OIE) said on Wednesday, citing a report from the
Russian farm ministry.
Read more
China top innovator with 1 million patent requests in year - UN
GENEVA, Nov 23 (Reuters) - China is driving Asian-led growth
in innovation worldwide, becoming the first country to file 1
million patent applications in a single year, the World
Intellectual Property Organization (WIPO) said on Wednesday.
Read more
in innovation worldwide, becoming the first country to file 1
million patent applications in a single year, the World
Intellectual Property Organization (WIPO) said on Wednesday.
Read more
BRIEF-Ceapro qtrly earnings per share $0.01
* Will "commence patient recruitment for pilot clinical
study to develop beta glucan as a cholesterol reducer in Q1
2017"
Read more
study to develop beta glucan as a cholesterol reducer in Q1
2017"
Read more
BRIEF-Kossan Rubber Industries to execute corporate guarantee
* Kossan will execute a corporate guarantee of rm30 million
in favour of Ocbc Bank (Malaysia) Bhd
Read more
in favour of Ocbc Bank (Malaysia) Bhd
Read more
BRIEF-Aurora Optoelectronics' Harbin unit signs equipment sales contract
* Says unit in Harbin signs equipment sales contract worth
189 million yuan ($27.41 million)
Read more
189 million yuan ($27.41 million)
Read more
BRIEF-Pangen Biotech signs contract worth 2.03 bln won
* Says it signs contract with Sam Chun Dang Pharm Co Ltd
to provide protein consignment production(CMO)
service
Read more
to provide protein consignment production(CMO)
service
Read more
German stocks - Factors to watch on November 23
FRANKFURT/BERLIN, Nov 23 (Reuters) - The DAX top-30 index
looked set to open 0.2 percent higher on Wednesday,
according to premarket data from brokerage Lang & Schwarz at
0711 GMT.
Read more
looked set to open 0.2 percent higher on Wednesday,
according to premarket data from brokerage Lang & Schwarz at
0711 GMT.
Read more
Tuesday, November 22, 2016
BRIEF-Biotest: study to record data on clinical use of Cytotect
* Biotest supports a large international retrospective study
to record data on clinical use of Cytotect(r) after heart and
lung transplantation
Read more
to record data on clinical use of Cytotect(r) after heart and
lung transplantation
Read more
BRIEF-Zosano Pharma announces sale of non-strategic asset
* Zosano Pharma Corp says has sold all of its interest in
Zosano Inc for an aggregate cash purchase price of $225,000
Read more
Zosano Inc for an aggregate cash purchase price of $225,000
Read more
BRIEF-Azure Healthcare requests trading halt
* Requests a trading halt pending release of an announcement
with regard to a capital raising proposal
Read more
with regard to a capital raising proposal
Read more
BRIEF-Medigus expands commercial availability of MUSE through distribution agreement with Innovamedica S.P.A. in Italy
* Medigus expands global commercial availability of MUSE
through distribution agreement with Innovamedica S.P.A. in
Italy; new agreement broadens medigus' accessibility in key
markets around the world
Read more
through distribution agreement with Innovamedica S.P.A. in
Italy; new agreement broadens medigus' accessibility in key
markets around the world
Read more
BRIEF-U.S. CDC says North Miami beach-designated area no longer considered area of active zika virus transmission
* North Miami beach-designated area no longer considered
area of active zika virus transmission; area is now designated
as zika cautionary area
Read more
area of active zika virus transmission; area is now designated
as zika cautionary area
Read more
BRIEF-Bristol-Myers' Opdivo gets European Commission approval for relapsed or refractory CHL treatment
* European Commission approves Bristol-Myers Squibb's Opdivo
(nivolumab) for the treatment of adult patients with relapsed or
refractory classical hodgkin lymphoma after autologous stem cell
transplant and treatment with brentuximab vedotin
Read more
(nivolumab) for the treatment of adult patients with relapsed or
refractory classical hodgkin lymphoma after autologous stem cell
transplant and treatment with brentuximab vedotin
Read more
BRIEF-Merck raises quarterly dividend to $0.47/share from $0.46/share
* Increased quarterly dividend to $0.47 per share, up $0.01
from $0.46 per outstanding share paid last quarter
Source text for Eikon:
Further company coverage:
Read more
from $0.46 per outstanding share paid last quarter
Source text for Eikon:
Further company coverage:
Read more
Include older children in malaria prevention treatment to cut transmission - experts
DAKAR, Nov 22 (Thomson Reuters Foundation) - Giving malaria
prevention drugs to older children, not just to those under
five, during the rainy season in sub-Saharan Africa can
massively cut cases and transmission of the deadly disease,
health experts said on Tuesday.
Read more
prevention drugs to older children, not just to those under
five, during the rainy season in sub-Saharan Africa can
massively cut cases and transmission of the deadly disease,
health experts said on Tuesday.
Read more
BRIEF-Parexel International to buy shares of its stock for $200 mln - SEC filing
* On Nov 21, Co entered agreement to buy shares of its stock
from HSBC Bank USA, National Association for $200 million-SEC
filing
Source text: (http://bit.ly/2fOzbhU)
Further company coverage:
Read more
from HSBC Bank USA, National Association for $200 million-SEC
filing
Source text: (http://bit.ly/2fOzbhU)
Further company coverage:
Read more
Civilian victims of mortar, sniper fire pour into Mosul clinic
KOKJALI, Iraq, Nov 22 (Reuters) - Iraqi military medics
rushed a man whose mouth had been blown apart by mortar shrapnel
into their temporary field clinic on the eastern edges of Mosul.
Read more
rushed a man whose mouth had been blown apart by mortar shrapnel
into their temporary field clinic on the eastern edges of Mosul.
Read more
UPDATE 1-U.S. FDA outlines data needed for over-the-counter sunscreen additives
Nov 22 (Reuters) - The U.S. Food and Drug Administration
issued guidelines on Tuesday detailing the data makers of
sunscreen sold over the counter need to produce to prove the
ingredients in the products are safe and effective.
Read more
issued guidelines on Tuesday detailing the data makers of
sunscreen sold over the counter need to produce to prove the
ingredients in the products are safe and effective.
Read more
Rally in basic resources stocks helps European indices
LONDON, Nov 22 (Reuters) - European mining shares rose more
than 3 percent on Tuesday, underpinning Europe's benchmark STOXX
600 index as the global reflation trade in the wake of Donald
Trump's victory in the U.S. presidential election continued.
Read more
than 3 percent on Tuesday, underpinning Europe's benchmark STOXX
600 index as the global reflation trade in the wake of Donald
Trump's victory in the U.S. presidential election continued.
Read more
BRIEF-Moscow Exchange suspends trading in Pharmstandard as of Nov. 29
* Says to suspend trading in Pharmstandard shares
as of November 29 because company has received tender offer
Read more
as of November 29 because company has received tender offer
Read more
Babies exposed to Zika developed microcephaly after birth -study
CHICAGO, Nov 22 (Reuters) - Thirteen babies in Brazil born
with normal head circumference have been diagnosed with
congenital Zika syndrome, with brain scans showing extensive
malformations, inflammation and reduced brain volume,
researchers reported on Tuesday.
Read more
with normal head circumference have been diagnosed with
congenital Zika syndrome, with brain scans showing extensive
malformations, inflammation and reduced brain volume,
researchers reported on Tuesday.
Read more
BRIEF-Amedica reports new sales leadership and provides regulatory updates
* FDA also notified company that new pedicle screw system,
taurus, has been cleared for commercialization
Read more
taurus, has been cleared for commercialization
Read more
BRIEF-Alfataliglicerase approved for pediatric indications in Brazil for the treatment of gaucher disease in children four years and older
* Alfataliglicerase approved for pediatric indications in
brazil for the treatment of gaucher disease in children four
years and older
Read more
brazil for the treatment of gaucher disease in children four
years and older
Read more
BRIEF-Biolinerx reports Q3 financial results
* Bioline RX Ltd - operating loss for three months ended
September 30, 2016 amounted to $4.5 million versus operating
loss of $3.6 million
Read more
September 30, 2016 amounted to $4.5 million versus operating
loss of $3.6 million
Read more
BRIEF-Baxter presented exploratory research on the removal of inflammation-related molecules during extracorporeal blood purification therapy
* Baxter International Inc - presented exploratory research
on the removal of inflammation-related molecules during
extracorporeal blood purification therapy
Read more
on the removal of inflammation-related molecules during
extracorporeal blood purification therapy
Read more
BRIEF-Immunovaccine's DPX-Survivac gets orphan drug designation by European medicines agency
* The european medicines agency grants orphan drug
designation status to Immunovaccine's DPX-Survivac in ovarian
cancer
Source text for Eikon:
Further company coverage:
Read more
designation status to Immunovaccine's DPX-Survivac in ovarian
cancer
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Uniqure reports Q3 loss per share EUR 0.54
* Uniqure Nv - Uniqure expects to realize EUR 5 million to
EUR 6 million of annualized cost savings by end of 2017
Read more
EUR 6 million of annualized cost savings by end of 2017
Read more
WIDER IMAGE-Hope for eradicating tuberculosis emerges in Peru slum
LIMA, Nov 22 (Reuters) - Now halfway through his treatment
for tuberculosis, William Campos, 49, is starting to imagine a
healthy life again.
Read more
for tuberculosis, William Campos, 49, is starting to imagine a
healthy life again.
Read more
BRIEF-NeuroSearch announces main components of resolution plan
* Sets resolution plan after Danish Supreme Court found co guilty of market manipulation
based on events occurring in H1 2010
Read more
based on events occurring in H1 2010
Read more
BRIEF-TWi Pharmaceuticals receives compensation $12.7 mln and interest for lawsuit of Megace ES generic medicine
* Says it received compensation $12.7 mln and interest for
lawsuit of Megace ES generic medicine from Par Pharmaceutical,
Inc
Read more
lawsuit of Megace ES generic medicine from Par Pharmaceutical,
Inc
Read more
BRIEF-Jilin Aodong Pharma to boost two units' registered capital
* Says it plans to boost two units' registered capital for a
combined 700 million yuan ($101.70 million)
Read more
combined 700 million yuan ($101.70 million)
Read more
BRIEF-United BioPharma completes issuing new shares for T$500 mln
* Says it completed issuing 12.5 million new shares at T$40
per share with amount of T$500 million
Read more
per share with amount of T$500 million
Read more
UPDATE 1-AstraZeneca cleared to resume enrolment in cancer drug trials
* Trials involve AstraZeneca's immunotherapy durvalumab
(Adds shares, further details on immunotherapy)
Read more
(Adds shares, further details on immunotherapy)
Read more
BRIEF-Hikma announces U.S. deal with Vectura for generic salmeterol development
* Announces agreement with Vectura for development of
generic salmeterol for U.S. market
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +91 806 749 1136)
Read more
generic salmeterol for U.S. market
Source text for Eikon:
Further company coverage:
(Bengaluru Newsroom: +91 806 749 1136)
Read more
UPDATE 2-UK Stocks-Factors to watch on Nov 22
Nov 22 (Reuters) - Britain's FTSE 100 index is seen opening up
around 44 points, or 0.7 percent, on Tuesday, according to financial bookmakers,
with futures up 0.8 percent ahead of the cash market open.
Read more
around 44 points, or 0.7 percent, on Tuesday, according to financial bookmakers,
with futures up 0.8 percent ahead of the cash market open.
Read more
Monday, November 21, 2016
BRIEF-Biophytis receives authorizations to conduct SARA-OBS study in sarcopenia patients
* Biophytis received regulatory authorizations to conduct SARA-OBS study in sarcopenia
patients
Read more
patients
Read more
BRIEF-Aevis Victoria 9-mth net revenues at CHF 367.8 mln
* Realised net revenues (medical fees excluded) of 367.8
million Swiss francs ($364.56 million)in first nine months of
2016 (373.0 million francs)
Read more
million Swiss francs ($364.56 million)in first nine months of
2016 (373.0 million francs)
Read more
UPDATE 3-Boeing taps GE exec to head airplanes unit as part of services push
NEW YORK, Nov 21 (Reuters) - Boeing Co on Monday
named a senior General Electric Co executive to head its
commercial airplanes division and announced a new services unit,
in moves to capture more of the profitable market for parts and
repairs after a jet is sold.
Read more
named a senior General Electric Co executive to head its
commercial airplanes division and announced a new services unit,
in moves to capture more of the profitable market for parts and
repairs after a jet is sold.
Read more
PRESS DIGEST- British Business - Nov 22
Nov 22 (Reuters) - The following are the top stories on the
business pages of British newspapers. Reuters has not verified
these stories and does not vouch for their accuracy.
Read more
business pages of British newspapers. Reuters has not verified
these stories and does not vouch for their accuracy.
Read more
BRIEF-Sanofi says receives FDA approval of Soliqua 100/33
* Sanofi receives FDA approval of Soliqua(tm) 100/33, for
the treatment of adults with type 2 diabetes
Read more
the treatment of adults with type 2 diabetes
Read more
DIARY-Malaysia 2016 corporate earnings
Following is a list of release dates for the quarterly earnings
of some top Malaysia-listed companies.
To submit a date, email: ananthalakshmi.as@tr.com
TBD: To be determined
Company RIC PERIOD DATE
AirAsia Bhd Q3 Nov 24
AirAsia X Bhd Q3 Nov 22
AMMB Holdings Bhd Q2 Nov 17-21
Astro Malaysia Holdings Bhd Q3 Dec 6-13
Axiata
Read more
of some top Malaysia-listed companies.
To submit a date, email: ananthalakshmi.as@tr.com
TBD: To be determined
Company RIC PERIOD DATE
AirAsia Bhd Q3 Nov 24
AirAsia X Bhd Q3 Nov 22
AMMB Holdings Bhd Q2 Nov 17-21
Astro Malaysia Holdings Bhd Q3 Dec 6-13
Axiata
Read more
BRIEF-Volpara Health Tech to undertake non-renounceable entitlement offer to raise about A$3.7 mln
* undertaking a 1 for 20 non-renounceable entitlement offer
to raise approximately a$3.7 million
Read more
to raise approximately a$3.7 million
Read more
BRIEF-Community Health Systems says units amended their existing accounts receivable securitization program
* On November 18, units amended their existing accounts
receivable securitization program - SEC filing
Read more
receivable securitization program - SEC filing
Read more
Deals of the day-Mergers and acquisitions
Nov 21 (Reuters) - The following bids, mergers, acquisitions
and disposals were reported by 2100 GMT on Monday:
Read more
and disposals were reported by 2100 GMT on Monday:
Read more
BRIEF-Corium International reports Q4 loss per share $0.42
* Corium reports fourth quarter and fiscal year 2016
financial results and recent corporate highlights
Read more
financial results and recent corporate highlights
Read more
BRIEF-Supersonic Imagine receives FDA 510(k) clearance for its new package
* Supersonic Imagine receives FDA 510(k) clearance for its
new innovative breast and liver package on Aixplorer
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
new innovative breast and liver package on Aixplorer
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
BRIEF-Onxeo announces another positive DSMB recommendation for Livatag
* Announces 9th positive DSMB recommendation to continue
Livatag relive phase III trial in HCC
Read more
Livatag relive phase III trial in HCC
Read more
UPDATE 1-Anthem argues that Fortune 500 won't suffer from Cigna deal
WASHINGTON, Nov 21 (Reuters) - Anthem Inc and the
U.S. Justice Department dug in their heels on Monday in court
over whether the lower prices the health insurer expects to
negotiate after buying smaller rival Cigna Corp are an
efficiency that benefits customers or an antitrust violation.
Read more
U.S. Justice Department dug in their heels on Monday in court
over whether the lower prices the health insurer expects to
negotiate after buying smaller rival Cigna Corp are an
efficiency that benefits customers or an antitrust violation.
Read more
BRIEF-U.S. senator Chuck Grassley says Mylan declining to testify at judiciary committee hearing
* Says Mylan declining to testify at judiciary committee
hearing on potential settlement between Mylan and DOJ
Source text - (http://bit.ly/2fy1MoP)
Further company coverage:
Read more
hearing on potential settlement between Mylan and DOJ
Source text - (http://bit.ly/2fy1MoP)
Further company coverage:
Read more
BRIEF-Spineway announces that TINAVI Medical Technologies has joined its capital
* Announces that Chinese company TINAVI Medical Technologies
has joined its capital, following a 1.4 million euros ($1.48
million) increase in capital
Source text for Eikon:
Further company coverage:
($1 = 0.9437 euros)
(Gdynia Newsroom)
Read more
has joined its capital, following a 1.4 million euros ($1.48
million) increase in capital
Source text for Eikon:
Further company coverage:
($1 = 0.9437 euros)
(Gdynia Newsroom)
Read more
BRIEF-Pfizer says Pfizer Global Supply President to retire
* Anthony J. Maddaluna, executive vice president and
president of Pfizer Global Supply to retire
Read more
president of Pfizer Global Supply to retire
Read more
UPDATE 3-Pope extends power to forgive abortion to all Roman Catholic priests
* Provision, in effect for Holy Year, extended indefinitely
(Adds comment by Boston College professor of moral theology)
Read more
(Adds comment by Boston College professor of moral theology)
Read more
Deals of the day-Mergers and acquisitions
Nov 21 (Reuters) - The following bids, mergers, acquisitions
and disposals were reported by 1500 GMT on Monday:
Read more
and disposals were reported by 1500 GMT on Monday:
Read more
BRIEF-ESSA secures US$10 million term loan from Silicon Valley Bank
* ESSA Pharma Inc says will initially draw down US$8 million
and has a conditional option to receive an additional US$2
million
Read more
and has a conditional option to receive an additional US$2
million
Read more
BRIEF-Genalyte says raised an additional $36 million in its latest financing round
* Genalyte Inc says raised an additional $36 million in its
latest financing round, led by Khosla Ventures and Redmile Group
Source text for Eikon:
Read more
latest financing round, led by Khosla Ventures and Redmile Group
Source text for Eikon:
Read more
BRIEF-Intelgenx secures a license for tadalafil erectile dysfunction dosing patent
* Intelgenx Technologies - announced signing of binding term
sheet for license to Eli Lilly and co's tadalafil dosing patent,
U.S. patent no. 6,943,166
Read more
sheet for license to Eli Lilly and co's tadalafil dosing patent,
U.S. patent no. 6,943,166
Read more
BRIEF-Rosetta Genomics enters research collaboration using microrna biomarkers to predict response to leading immuno-oncology drug nivolumab in lung cancer patients
* Rosetta genomics enters research collaboration using
microrna biomarkers to predict response to leading
immuno-oncology drug nivolumab in lung cancer patients
Source text for Eikon:
Further company coverage:
Read more
microrna biomarkers to predict response to leading
immuno-oncology drug nivolumab in lung cancer patients
Source text for Eikon:
Further company coverage:
Read more
BRIEF-SSY Group says unit in Shijiazhuang suspends production as directed
* Shijiazhuang, City Government of Shijiazhuang, ordered
companies of pharma, iron casting, cement to temporarily halt
production processes
Read more
companies of pharma, iron casting, cement to temporarily halt
production processes
Read more
BRIEF-Livzon Pharma's controlling shareholder Joincare's unit bought H-shares in the company
* Says controlling shareholder Joincare Pharma's
unit has bought 8.5 million H-shares in the company on Nov 18,
taking its holding to 17.5 percent after transaction
Read more
unit has bought 8.5 million H-shares in the company on Nov 18,
taking its holding to 17.5 percent after transaction
Read more
Fitch: Rising Price Pressures Reshaping European HY Healthcare
(The following statement was released by the rating agency)
Link to Fitch Ratings' Report: European High-Yield Healthcare
Handbook
https://www.fitchratings.com/site/re/890177
LONDON, November 21 (Fitch) Pricing pressure on European
healthcare companies
will broaden to every subsector as governments' focus on value
in healthcare
increases, Fitch Ratings says. This will reshape the high-yield
segment of the
market, putting pressure on some niche operators, driving
further M&A in
subsectors whe
Read more
Link to Fitch Ratings' Report: European High-Yield Healthcare
Handbook
https://www.fitchratings.com/site/re/890177
LONDON, November 21 (Fitch) Pricing pressure on European
healthcare companies
will broaden to every subsector as governments' focus on value
in healthcare
increases, Fitch Ratings says. This will reshape the high-yield
segment of the
market, putting pressure on some niche operators, driving
further M&A in
subsectors whe
Read more
BRIEF-Ssy Group seeks trading halt
* Trading in shares of company will be halted with effect
from 9:16 a.m. On 21 november 2016
Source text for Eikon:
Further company coverage:
Read more
from 9:16 a.m. On 21 november 2016
Source text for Eikon:
Further company coverage:
Read more
Denmark detects first H5N8 bird flu at poultry farm
COPENHAGEN, Nov 21 (Reuters) - The first case of H5N8 bird
flu has been detected at a poultry farm in Denmark, the
country's environment and food ministry said on Monday.
Read more
flu has been detected at a poultry farm in Denmark, the
country's environment and food ministry said on Monday.
Read more
BRIEF-China Tianying unit plans project firm in Chongqing
* Says its unit plans to set up a wholly owned subsidiary as
project firm to operate garbage incineration power generation
project, with investment of 168 million yuan
Read more
project firm to operate garbage incineration power generation
project, with investment of 168 million yuan
Read more
BRIEF-Eukedos unit, Edos, signs loan agreement for EUR 5.5 mln
* Said on Friday its unit, Edos Srl, signed loan agreement
with ICCREA BancaImpresa related to acquisition of RSA Bramante
Read more
with ICCREA BancaImpresa related to acquisition of RSA Bramante
Read more
BRIEF-GreenPeptide to buy shares of Japan-based firm via private placement
* Says it plans to buy about 67 percent stake in a
Japan-based firm via private placement on Dec. 1
Read more
Japan-based firm via private placement on Dec. 1
Read more
BRIEF-Poxel to present new imeglimin data demonstrating beta cell function preservation
* To present new imeglimin data demonstrating beta cell
function preservation at the 14th annual world congress on
insulin resistance, diabetes & cardiovascular disease
Read more
function preservation at the 14th annual world congress on
insulin resistance, diabetes & cardiovascular disease
Read more
Sunday, November 20, 2016
BRIEF-Panacea Biotec announces receipt of EIR from USFDA
* Panacea Biotec Ltd. announces receipt of establishment
inspection report (EIR) from USFDA
Source text: http://corporates.bseindia.com/xml-data/corpfiling/AttachLive/462A15FE_20FB_40A7_883F_3D22A0646DA7_104704.pdf
Further company coverage:
Read more
inspection report (EIR) from USFDA
Source text: http://corporates.bseindia.com/xml-data/corpfiling/AttachLive/462A15FE_20FB_40A7_883F_3D22A0646DA7_104704.pdf
Further company coverage:
Read more
BRIEF-Shanghai Shyndec Pharmaceutical names new chairman, general manager and CFO
* Says it names Zhou Bin as chairman of the board, Jia
Zhidan as general manager, and Li Hao as CFO
Read more
Zhidan as general manager, and Li Hao as CFO
Read more
BRIEF-Shanxi C&Y Pharmaceutical Group shareholder unloads 3.65 pct stake in co
* Says its shareholder Zhang Tonghui has reduced its
shareholdings in the company by sale of 7.6 million shares (3.65
percent stake) via block trade, and holds 4.33 percent stake
down from 7.98 percent after trannsaction
Read more
shareholdings in the company by sale of 7.6 million shares (3.65
percent stake) via block trade, and holds 4.33 percent stake
down from 7.98 percent after trannsaction
Read more
BRIEF-North China Parmaceutical and its units have suspended production
* Says it and its units have suspended production due to the
government's pollution controlling measures
Read more
government's pollution controlling measures
Read more
BRIEF-Vital Healthcare Property Trust announces acquisition of a majority interest in Ekera Medical Centre
* Announced acquisition of a majority interest in ekera
medical centre at box hill in melbourne for A$24.4mln
Source text for Eikon:
Further company coverage:
Read more
medical centre at box hill in melbourne for A$24.4mln
Source text for Eikon:
Further company coverage:
Read more
Merkel's Bavarian allies welcome her decision to run for 4th term
MUNICH, Germany, Nov 20 (Reuters) - The head of German
Chancellor Angela Merkel's conservative allies in Bavaria
welcomed her decision on Sunday to run for a fourth term in next
year's election.
Read more
Chancellor Angela Merkel's conservative allies in Bavaria
welcomed her decision on Sunday to run for a fourth term in next
year's election.
Read more
Saturday, November 19, 2016
Pioneering U.S. heart surgeon, Denton Cooley, dies at 96
Nov 18 (Reuters) - Dr. Denton Cooley, who sparked
controversy and a feud with another pioneering heart surgeon
when he performed the world's first artificial heart implant in
1969, died on Friday at the age of 96, the Texas Heart Institute
said.
Read more
controversy and a feud with another pioneering heart surgeon
when he performed the world's first artificial heart implant in
1969, died on Friday at the age of 96, the Texas Heart Institute
said.
Read more
Friday, November 18, 2016
BRIEF-La Jolla Pharmaceutical files for mixed shelf of up to $150 million
* La Jolla Pharmaceutical Co - files for mixed shelf of up
to $150 million - sec filing
Source text (http://bit.ly/2grTKCP)
Further company coverage:
Read more
to $150 million - sec filing
Source text (http://bit.ly/2grTKCP)
Further company coverage:
Read more
UPDATE 2-WHO declares end of Zika emergency, but still urges action
GENEVA, Nov 18 (Reuters) - The World Health Organization
(WHO) declared on Friday that the Zika virus no longer
constitutes an international emergency, but it stressed a need
for a long-term effort to address Zika, which has been linked to
birth defects and neurological complications.
Read more
(WHO) declared on Friday that the Zika virus no longer
constitutes an international emergency, but it stressed a need
for a long-term effort to address Zika, which has been linked to
birth defects and neurological complications.
Read more
BRIEF-Moleculin Biotech-audit committee determined co's financial statements for quarter ended June 30, 2016 should no longer be relied upon
* Moleculin Biotech - a liability in amount of $750,000
should not have been reflected in balance sheet as of June 30,
2016
Read more
should not have been reflected in balance sheet as of June 30,
2016
Read more
BRIEF-Hooper Holmes says entered into fourth amendment to credit agreement
* On November 15, 2016, company entered into a fourth
amendment to credit agreement - sec filing
Read more
amendment to credit agreement - sec filing
Read more
BRIEF-Immunomedics confirms venBio has submitted notice of director nomination
* Immunomedics - confirmed that venBio Select Advisor LLC
has submitted a notice of nomination of four director candidates
to stand for election to co's board
Read more
has submitted a notice of nomination of four director candidates
to stand for election to co's board
Read more
BRIEF-Pfizer announces pricing of tender offer for any and all of its 6.200 pct senior notes due March 15, 2019
* Pfizer announces pricing of tender offer for any and all
of its 6.200 pct senior notes due March 15, 2019
Source text for Eikon:
Further company coverage:
Read more
of its 6.200 pct senior notes due March 15, 2019
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Motif Bio Plc's ADS opens at $5.52 in U.S. market debut
* Motif Bio Plc's ADS opens at $5.52 in U.S. market debut,
below the IPO price of $6.98 per ADS
Further company coverage:
Read more
below the IPO price of $6.98 per ADS
Further company coverage:
Read more
WHO declares end of Zika emergency but still needs action
GENEVA, Nov 18 (Reuters) - The World Health Organization
(WHO) declared on Friday that the Zika virus and related
neurological complications no longer constitute an international
emergency but said that it would continue to work on the
outbreak through a "robust programme".
Read more
(WHO) declared on Friday that the Zika virus and related
neurological complications no longer constitute an international
emergency but said that it would continue to work on the
outbreak through a "robust programme".
Read more
Fitch Assigns First-Time 'BB-' Rating to MedImpact; Outlook Positive
(The following statement was released by the rating agency)
CHICAGO, November 18 (Fitch) Fitch Ratings has assigned a 'BB-'
Issuer Default
Rating to MedImpact Holdings, Inc. and its issuing subsidiary,
MI OpCo Holdings,
Inc. The Rating Outlook is Positive.
A full list of rating actions follows at the end of this
release.
KEY RATING DRIVERS
Smaller Scale in Consolidated Industry: MedImpact is a top-5
pharmacy benefit
manager (PBM) but is significantly smaller than its three
largest competitor
Read more
CHICAGO, November 18 (Fitch) Fitch Ratings has assigned a 'BB-'
Issuer Default
Rating to MedImpact Holdings, Inc. and its issuing subsidiary,
MI OpCo Holdings,
Inc. The Rating Outlook is Positive.
A full list of rating actions follows at the end of this
release.
KEY RATING DRIVERS
Smaller Scale in Consolidated Industry: MedImpact is a top-5
pharmacy benefit
manager (PBM) but is significantly smaller than its three
largest competitor
Read more
BRIEF-SHL comments on tax related court decision in Israel
* Court house in Tel Aviv today decided to reject most of company's appeals against ITA
(Israeli Tax Authority) thus creating an increase in financial liability to ITA in amount of
approx. $5.5 million
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
(Israeli Tax Authority) thus creating an increase in financial liability to ITA in amount of
approx. $5.5 million
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
Novartis backs off from 2016 date for testing Google autofocus lens
ZURICH, Nov 18 (Reuters) - Novartis has abandoned a
2016 goal to start testing its autofocus contact lens on people,
though it said the groundbreaking product it is making with
internet giant Google is "progressing steadily."
Read more
2016 goal to start testing its autofocus contact lens on people,
though it said the groundbreaking product it is making with
internet giant Google is "progressing steadily."
Read more
Nigeria fights myths, fear in polio vaccine drive
ABUJA, Nov 18 (Thomson Reuters Foundation) - Two years after
Nigerian militant group Boko Haram attacked his hometown of
Gwoza - killing men and burning down houses - Ali Bello feared
the worst when he received a panicked message from his wife.
Read more
Nigerian militant group Boko Haram attacked his hometown of
Gwoza - killing men and burning down houses - Ali Bello feared
the worst when he received a panicked message from his wife.
Read more
Fitch Rates Abbott's Notes Offering 'A(EXP)'; Rating Watch Negative
(The following statement was released by the rating agency)
CHICAGO, November 18 (Fitch) Fitch Ratings has assigned an
'A(EXP)' rating with
a Negative Rating Watch to Abbott Laboratories' (ABT, Abbott)
notes offering.
The net proceeds are expected to be used to fund the company's
acquisition of
St. Jude Medical Inc. (STJ, St. Jude). Abbott is also in the
process of
potentially acquiring Alere Inc. (Alere).
Fitch will resolve the Rating Watch as more details regarding
the transaction
become
Read more
CHICAGO, November 18 (Fitch) Fitch Ratings has assigned an
'A(EXP)' rating with
a Negative Rating Watch to Abbott Laboratories' (ABT, Abbott)
notes offering.
The net proceeds are expected to be used to fund the company's
acquisition of
St. Jude Medical Inc. (STJ, St. Jude). Abbott is also in the
process of
potentially acquiring Alere Inc. (Alere).
Fitch will resolve the Rating Watch as more details regarding
the transaction
become
Read more
BRIEF-Astellas says extends commitment with Canadian Urological Association
* Astellas Pharma Canada says renewal of Canadian Urological
Association Astellas Research Grant Program for an additional
three years
Source text for Eikon:
Further company coverage:
Read more
Association Astellas Research Grant Program for an additional
three years
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Argos says AGS-003-like therapy showed favorable effects in murine model of RCC
* Argos Therapeutics- data showed favorable effects of
AGS-003-like therapy as single agent in murine model of RCC
Read more
AGS-003-like therapy as single agent in murine model of RCC
Read more
BRIEF-Mallinckrodt announces results from clinical pharmacokinetic study examining effect of IV Morphine
* Mallinckrodt plc - results from clinical pharmacokinetic
study examining effect of iv morphine on absorption of orally
administered acetaminophen
Read more
study examining effect of iv morphine on absorption of orally
administered acetaminophen
Read more
BRIEF-Medicure exercises option to acquire majority interest in Apicore
* Medicure inc- continues to have option rights until july
3, 2017 to acquire additional shares in Apicore
Read more
3, 2017 to acquire additional shares in Apicore
Read more
BRIEF-1St available ltd withdraws proposal to acquire Ozdocsonline
* 1st withdraws proposal to acquire ozdocsonline
Source text for Eikon:
Further company coverage:
Read more
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Immunicum Q1 operating loss widens to SEK 12.0 million
* Q1 operating loss 12.0 million Swedish crowns ($1.3
million)versus loss 7.8 million crowns year ago
Source text for Eikon:
Read more
million)versus loss 7.8 million crowns year ago
Source text for Eikon:
Read more
Thursday, November 17, 2016
BRIEF-I'rom Group unit gets patent grant in Japan and U.S. for cells production technology
* Says its unit received patent grant in Japan and the U.S.
for production technology of pluripotent stem cells and brown
adipose cells
Read more
for production technology of pluripotent stem cells and brown
adipose cells
Read more
BRIEF-Triphase Accelerator says Celgene will buy co's assets related to marizomib
* says Celgene Corp, through an affiliate, has acquired co's
assets related to its proteasome inhibitor, marizomib
Read more
assets related to its proteasome inhibitor, marizomib
Read more
S.Korea confirms outbreaks of highly pathogenic bird flu at two poultry farms
SEOUL, Nov 18 (Reuters) - South Korea has confirmed the
country's first outbreaks of the highly pathogenic H5N6 bird flu
virus at two poultry farms, an agriculture ministry official
said on Friday.
Read more
country's first outbreaks of the highly pathogenic H5N6 bird flu
virus at two poultry farms, an agriculture ministry official
said on Friday.
Read more
BRIEF-Triphase Accelerator says Celgene will buy co's assets related to marizomib
* says Celgene Corp, through an affiliate, has acquired co's
assets related to its proteasome inhibitor, marizomib
Read more
assets related to its proteasome inhibitor, marizomib
Read more
U.S. approves possible sale of defense aircraft to Qatar, Kuwait
WASHINGTON, Nov 17 (Reuters) - The U.S. State Department
notified Congress on Thursday of the possible sale of F-15QA
aircraft to Qatar for $21.1 billion and F/A-18E/F aircraft to
Kuwait for $10.1 billion, the U.S. Defense Security Cooperation
Agency said in a statement.
Read more
notified Congress on Thursday of the possible sale of F-15QA
aircraft to Qatar for $21.1 billion and F/A-18E/F aircraft to
Kuwait for $10.1 billion, the U.S. Defense Security Cooperation
Agency said in a statement.
Read more
DIARY-Malaysia 2016 corporate earnings
Following is a list of release dates for the quarterly earnings
of some top Malaysia-listed companies.
To submit a date, email: ananthalakshmi.as@tr.com
TBD: To be determined
Company RIC PERIOD DATE
AirAsia Bhd Q3 Nov 24
AirAsia X Bhd Q3 Nov 22
AMMB Holdings Bhd Q2 Nov 17-21
Astro Malaysia Holdings Bhd Q3 Dec 6-13
Axiata
Read more
of some top Malaysia-listed companies.
To submit a date, email: ananthalakshmi.as@tr.com
TBD: To be determined
Company RIC PERIOD DATE
AirAsia Bhd Q3 Nov 24
AirAsia X Bhd Q3 Nov 22
AMMB Holdings Bhd Q2 Nov 17-21
Astro Malaysia Holdings Bhd Q3 Dec 6-13
Axiata
Read more
BRIEF-GlobeImmune announces updates
* GlobeImmune Inc says Gilead Sciences Inc has terminated
collaboration and license agreement with company
Read more
collaboration and license agreement with company
Read more
BRIEF-Agilent Technologies increases cash dividend to 13.2 cents per share
* Agilent Technologies increases cash dividend to 13.2 cents
per share
Source text for Eikon:
Further company coverage:
Read more
per share
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Medtronic says data demonstrates Heli-FX EndoAnchor system enhances outcomes, durability in patients
* Medtronic says data demonstrates Heli-FX EndoAnchor system
enhances outcomes,durability in patients with complex aortic
abdominal aneurysm (AAA) anatomy
Read more
enhances outcomes,durability in patients with complex aortic
abdominal aneurysm (AAA) anatomy
Read more
BRIEF-Oncogenex Pharmaceuticals says committed to further reduction in workforce
* Will eliminate 5 positions and estimates that will incur
about $750,000 in cash expenditures as a result
Read more
about $750,000 in cash expenditures as a result
Read more
UPDATE 1-McDonald's investor renews push for antibiotic reduction in all meat
Nov 17 (Reuters) - A McDonald's Corp shareholder is
redoubling efforts to convince the fast-food chain to stop all
of its global restaurants from serving the meat of animals
raised with antibiotics that are vital for fighting human
infections.
Read more
redoubling efforts to convince the fast-food chain to stop all
of its global restaurants from serving the meat of animals
raised with antibiotics that are vital for fighting human
infections.
Read more
UPDATE 1-Surgeon General calls for action to fight drug, alcohol abuse
WASHINGTON, Nov 17 (Reuters) - The U.S. Surgeon General
issued a call to action on Thursday to end what he called a
public health crisis of drug and alcohol addiction that is
underappreciated and undertreated.
Read more
issued a call to action on Thursday to end what he called a
public health crisis of drug and alcohol addiction that is
underappreciated and undertreated.
Read more
WHO says funds secured for Africa pilots of world's first malaria vaccine
LONDON, Nov 17 (Reuters) - Funding for phase one of pilot
deployments of the world's first malaria vaccine in sub-Saharan
Africa has been secured and immunisation campaigns will begin in
2018, the World Health Organization (WHO) said on Thursday.
Read more
deployments of the world's first malaria vaccine in sub-Saharan
Africa has been secured and immunisation campaigns will begin in
2018, the World Health Organization (WHO) said on Thursday.
Read more
BRIEF-The Female Health Co says plans to launch Preboost in U.S. before year-end
* The Female Health Company / Veru Healthcare reports
interim analysis of independent placebo controlled clinical
study of Preboost, its proprietary premature ejaculation
medication
Read more
interim analysis of independent placebo controlled clinical
study of Preboost, its proprietary premature ejaculation
medication
Read more
Obama says would support Trump moves to improve U.S. healthcare
BERLIN, Nov 17 (Reuters) - U.S. President Barack Obama said
on Thursday he would support any move by President-elect Donald
Trump to improve healthcare for Amercicans.
Read more
on Thursday he would support any move by President-elect Donald
Trump to improve healthcare for Amercicans.
Read more
BRIEF-Endo announces positive data from Phase 2b study of collagenase clostridium histolyticum (cch)
* Endo announces positive data from phase 2b study of
collagenase clostridium histolyticum (cch) in patients with
cellulite
Read more
collagenase clostridium histolyticum (cch) in patients with
cellulite
Read more
BRIEF-Catabasis Pharma provides edasalonexent and rare disease pipeline updates at investor day
* Catabasis Pharma- Top-line safety and efficacy results
from placebo-controlled portion of movedmd phase 2 trial are
expected in first half of Q1 2017
Read more
from placebo-controlled portion of movedmd phase 2 trial are
expected in first half of Q1 2017
Read more
BRIEF-Ra Pharmaceuticals receives orphan drug designation in the European Union for RA101495 for Treatment of Paroxysmal Nocturnal Hemoglobinuria
* Ra Pharmaceuticals receives orphan drug designation in the
European Union for RA101495 for Treatment of Paroxysmal
Nocturnal Hemoglobinuria
Source text for Eikon:
Further company coverage:
Read more
European Union for RA101495 for Treatment of Paroxysmal
Nocturnal Hemoglobinuria
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Biofrontera: capital increase 5,012,950 new shares fully placed
* Capital increase: 5,012,950 new shares fully placed
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
Source text for Eikon:
Further company coverage:
(Gdynia Newsroom)
Read more
BRIEF-WSE resumes trading of B2Bpartner, Inno-Gene and Provecta IT
* Said on Wednesday that it decided to resume trading of
shares of B2Bpartner SA, Inno-Gene SA and
Provecta IT SA as of Nov. 17 as the companies published
their quarterly reports for Q3 2016
Source text: http://bit.ly/2g11FTX
Read more
shares of B2Bpartner SA, Inno-Gene SA and
Provecta IT SA as of Nov. 17 as the companies published
their quarterly reports for Q3 2016
Source text: http://bit.ly/2g11FTX
Read more
UPDATE 2-UK Stocks-Factors to watch on Nov 17
Nov 17 (Reuters) - Britain's FTSE 100 index is seen opening up 19 to
21 points, or as much as 0.3 percent, on Thursday, according to financial
bookmakers, with futures up 0.04 percent ahead of the cash market open.
Read more
21 points, or as much as 0.3 percent, on Thursday, according to financial
bookmakers, with futures up 0.04 percent ahead of the cash market open.
Read more
Wednesday, November 16, 2016
BRIEF-Brighter: Camanio Care carries out issue of units prior to listing
* Said on Wednesday its subsidiary Camanio Care AB had decided to carry out
private placement of units of total of 9.4 million Swedish crowns ($1 million)
Read more
private placement of units of total of 9.4 million Swedish crowns ($1 million)
Read more
PRESS DIGEST - Wall Street Journal - Nov 17
Nov 17 (Reuters) - The following are the top stories in the
Wall Street Journal. Reuters has not verified these stories and
does not vouch for their accuracy.
Read more
Wall Street Journal. Reuters has not verified these stories and
does not vouch for their accuracy.
Read more
Starboard Value up more than 10 pct, led by Depomed stake -document
NEW YORK, Nov 16 (Reuters) - Starboard Value, the activist
hedge fund behind shake-ups at Yahoo Inc and Marvell
Technology Group Ltd, has notched an investment return
of more than 10 percent this year on the back of boardroom deals
and takeovers.
Read more
hedge fund behind shake-ups at Yahoo Inc and Marvell
Technology Group Ltd, has notched an investment return
of more than 10 percent this year on the back of boardroom deals
and takeovers.
Read more
Japan sets 50 pct price cut for Opdivo cancer drug: Ono Pharma
Nov 16 (Reuters) - A Japanese health ministry council has
approved a 50 percent cut in the price of Opdivo, a costly
immune system-boosting cancer drug produced by Bristol Myers
Squibb Co and marketed in the country by Ono
Pharmaceutical Co Ltd.
Read more
approved a 50 percent cut in the price of Opdivo, a costly
immune system-boosting cancer drug produced by Bristol Myers
Squibb Co and marketed in the country by Ono
Pharmaceutical Co Ltd.
Read more
DIARY-Malaysia 2016 corporate earnings
Following is a list of release dates for the quarterly earnings
of some top Malaysia-listed companies.
To submit a date, email: ananthalakshmi.as@tr.com
TBD: To be determined
Company RIC PERIOD DATE
AirAsia Bhd Q3 Nov 24
AirAsia X Bhd Q3 Nov 22
AMMB Holdings Bhd Q2 Nov 17-21
Astro Malaysia Holdings Bhd Q3 Dec 6-13
Axiata
Read more
of some top Malaysia-listed companies.
To submit a date, email: ananthalakshmi.as@tr.com
TBD: To be determined
Company RIC PERIOD DATE
AirAsia Bhd Q3 Nov 24
AirAsia X Bhd Q3 Nov 22
AMMB Holdings Bhd Q2 Nov 17-21
Astro Malaysia Holdings Bhd Q3 Dec 6-13
Axiata
Read more
BRIEF-Tenet Healthcare says upsized and priced offering of senior notes
* Tenet announces upsizing and pricing of its private
offering of senior secured second lien notes
Read more
offering of senior secured second lien notes
Read more
DIARY-Malaysia 2016 corporate earnings
Following is a list of release dates for the quarterly earnings
of some top Malaysia-listed companies.
To submit a date, email: ananthalakshmi.as@tr.com
TBD: To be determined
Company RIC PERIOD DATE
AirAsia Bhd Q3 Nov 24
AirAsia X Bhd Q3 Nov 22
AMMB Holdings Bhd Q2 Nov 17-21
Astro Malaysia Holdings Bhd Q3 Dec 6-13
Axiata
Read more
of some top Malaysia-listed companies.
To submit a date, email: ananthalakshmi.as@tr.com
TBD: To be determined
Company RIC PERIOD DATE
AirAsia Bhd Q3 Nov 24
AirAsia X Bhd Q3 Nov 22
AMMB Holdings Bhd Q2 Nov 17-21
Astro Malaysia Holdings Bhd Q3 Dec 6-13
Axiata
Read more
BRIEF-Tenet Healthcare says upsized and priced offering of senior notes
* Tenet announces upsizing and pricing of its private
offering of senior secured second lien notes
Read more
offering of senior secured second lien notes
Read more
BRIEF-Gilead announces top-line results from two phase 3 studies
* Gilead Sciences Inc - non-inferiority was not achieved for
key secondary endpoint of response rate in total symptom score
(TSS)
Read more
key secondary endpoint of response rate in total symptom score
(TSS)
Read more
BRIEF-Amgen announces Erenumab significantly reduces monthly migraine days in patients with episodic migraine in second phase 3 study
* Amgen announces Erenumab significantly reduces monthly
migraine days in patients with episodic migraine in second phase
3 study
Read more
migraine days in patients with episodic migraine in second phase
3 study
Read more
New drug capsule delivers medicine for weeks after swallowing
LONDON, Nov 16 (Reuters) - Scientists have developed a new
drug capsule that stays in the stomach for up to two weeks after
being swallowed, gradually releasing its payload.
Read more
drug capsule that stays in the stomach for up to two weeks after
being swallowed, gradually releasing its payload.
Read more
BRIEF-Akers Biosciences files for potential stock shelf, size not disclosed
* Files for potential stock shelf; size not disclosed - sec
filing
Source text : http://bit.ly/2fGeOku
Further company coverage:
Read more
filing
Source text : http://bit.ly/2fGeOku
Further company coverage:
Read more
BRIEF-Rosalind Advisors reports 11.2 pct passive stake in Zosano Pharma
* Rosalind advisors inc reports 11.2 percent passive stake
in zosano pharma corp as of november 1 - sec filing
Source text : http://bit.ly/2fFZDrr
Further company coverage:
Read more
in zosano pharma corp as of november 1 - sec filing
Source text : http://bit.ly/2fFZDrr
Further company coverage:
Read more
BRIEF-Mithra Pharmaceuticals signs a LOI for the Chinese rights on Estetrol with Zhejiang Xianju Pharmaceutical
* Mithra Pharmaceuticals SA signs a LOI for the Chinese rights on Estetrol in women's health
with the market leader in women's health in China, Zhejiang Xianju Pharmaceutical
Read more
with the market leader in women's health in China, Zhejiang Xianju Pharmaceutical
Read more
Myanmar refugee doctor wins humanitarian prize for clinic in Thailand
LONDON, Nov 16 (Thomson Reuters Foundation) - When Cynthia
Maung saw the suffering of fellow refugees who had fled
Myanmar's crackdown on a pro-democracy uprising in the late
1980s and sought sanctuary in neighbouring Thailand, she knew
she had to do something about it.
Read more
Maung saw the suffering of fellow refugees who had fled
Myanmar's crackdown on a pro-democracy uprising in the late
1980s and sought sanctuary in neighbouring Thailand, she knew
she had to do something about it.
Read more
BRIEF-Endologix says positive five-year results from global Ovation pivotal trial
* Positive five-year results from the global ovation
pivotal trial presented at 2016 veith symposium
Read more
pivotal trial presented at 2016 veith symposium
Read more
BRIEF-Micropos Medical: New distributor in Poland
* Says has signed a distribution agreement with Health Technologies for the distribution of
RayPilot in Poland
Read more
RayPilot in Poland
Read more
BRIEF-Zdi Solutions, LLC receives FDA approval for patented proton therapy
* ZDi solutions, LLC receives FDA approval for patented
proton therapy & conventional radiation therapy positioning
devices
Source text for Eikon:
Read more
proton therapy & conventional radiation therapy positioning
devices
Source text for Eikon:
Read more
BRIEF-Surmodics sees FY 2017 revenue $63 million to $67 million
* Surmodics Inc - capital expenditures for fiscal 2017 are
projected to range between $7.0 million and $8.0 million
Read more
projected to range between $7.0 million and $8.0 million
Read more
BRIEF-Allergan announces partnership with Amy Dixon, Elite Paratriathlete
* Allergan announces partnership with Amy Dixon, Elite
Paratriathlete, to improve patient-physician conversations about
irritable bowel syndrome with diarrhea (ibs-d)
Source text for Eikon:
Further company coverage:
Read more
Paratriathlete, to improve patient-physician conversations about
irritable bowel syndrome with diarrhea (ibs-d)
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Immunocellular Therapeutics reports one-for-forty reverse stock split
* Immunocellular Therapeutics announces one-for-forty
reverse stock split
Source text for Eikon:
Further company coverage:
Read more
reverse stock split
Source text for Eikon:
Further company coverage:
Read more
BRIEF-Inno-Gene Q3 net profit rises to 118,696 zlotys YOY
* Reported on Tuesday Q3 revenue of 1.5 million zlotys
($364,662) versus 1.4 million zlotys a year ago
Read more
($364,662) versus 1.4 million zlotys a year ago
Read more
BRIEF-Asymchem Laboratories Tianjin's share trade to debut on Nov 18
* Shenzhen stock exchange says Asymchem Laboratories
Tianjin's share trade to debut on Nov 18
Source text in Chinese: http://bit.ly/2eZn7pS
(Reporting by Hong Kong newsroom)
Read more
Tianjin's share trade to debut on Nov 18
Source text in Chinese: http://bit.ly/2eZn7pS
(Reporting by Hong Kong newsroom)
Read more
BRIEF-Sprint Bioscience Q3 operating result turns to profit of SEK 0.5 mln
* Q3 revenue 10.8 million Swedish crowns ($1.18 million) versus 4.9 million crowns year ago
Read more
Read more
Soap opera: South Korea's Park "used starlet as pseudonym" at detox clinic
SEOUL, Nov 16 (Reuters) - The starlet of a TV soap became
the most talked-about celebrity in South Korea on Wednesday when
a TV channel revealed President Park Geun-hye once used her name
as a pseudonym at a beauty and detox clinic, a distraction from
the scandal engulfing her administration.
Read more
the most talked-about celebrity in South Korea on Wednesday when
a TV channel revealed President Park Geun-hye once used her name
as a pseudonym at a beauty and detox clinic, a distraction from
the scandal engulfing her administration.
Read more
Tuesday, November 15, 2016
BRIEF-Probiodrug: first results of preclinical study with pGlu3-Abeta-specific antibody mPBD-C06
* Probiodrug /Amyloid-beta (Abeta) aggregate-clearing by the
murine anti-pyroglutamate-3 Abeta IgG2a monoclonal antibody
PBD-C06 with and without a complement mutation in an Alzheimer's
mouse model
Read more
murine anti-pyroglutamate-3 Abeta IgG2a monoclonal antibody
PBD-C06 with and without a complement mutation in an Alzheimer's
mouse model
Read more
BRIEF-Platform Partners Asset Management buys 10.1 pct stake in MG Med
* Says Platform Partners Asset Management Co., Ltd has
acquired 234,329 shares of the company, representing a 10.1
percent stake
Read more
acquired 234,329 shares of the company, representing a 10.1
percent stake
Read more
DIARY-Malaysia 2016 corporate earnings
Following is a list of release dates for the quarterly earnings
of some top Malaysia-listed companies.
To submit a date, email: ananthalakshmi.as@tr.com
TBD: To be determined
Company RIC PERIOD DATE
AirAsia Bhd Q3 Nov 24
AirAsia X Bhd Q3 Nov 22
AMMB Holdings Bhd Q2 Nov 17-21
Astro Malaysia Holdings Bhd Q3 Dec 6-13
Axiata
Read more
of some top Malaysia-listed companies.
To submit a date, email: ananthalakshmi.as@tr.com
TBD: To be determined
Company RIC PERIOD DATE
AirAsia Bhd Q3 Nov 24
AirAsia X Bhd Q3 Nov 22
AMMB Holdings Bhd Q2 Nov 17-21
Astro Malaysia Holdings Bhd Q3 Dec 6-13
Axiata
Read more
BRIEF-Emerald Health announces no material change
* is issuing press release in response to request by
investment industry regulatory organization of Canada
Read more
investment industry regulatory organization of Canada
Read more
DIARY-Malaysia 2016 corporate earnings
Following is a list of release dates for the quarterly earnings
of some top Malaysia-listed companies.
To submit a date, email: ananthalakshmi.as@tr.com
TBD: To be determined
Company RIC PERIOD DATE
AirAsia Bhd Q3 Nov 24
AirAsia X Bhd Q3 Nov 22
AMMB Holdings Bhd Q2 Nov 17-21
Astro Malaysia Holdings Bhd Q3 Dec 6-13
Axiata
Read more
of some top Malaysia-listed companies.
To submit a date, email: ananthalakshmi.as@tr.com
TBD: To be determined
Company RIC PERIOD DATE
AirAsia Bhd Q3 Nov 24
AirAsia X Bhd Q3 Nov 22
AMMB Holdings Bhd Q2 Nov 17-21
Astro Malaysia Holdings Bhd Q3 Dec 6-13
Axiata
Read more
BRIEF-Emerald Health announces no material change
* is issuing press release in response to request by
investment industry regulatory organization of Canada
Read more
investment industry regulatory organization of Canada
Read more
BRIEF-Hans Biomed to pay interim dividend as 100 won per share
* Says it will pay interim dividend to shareholders recorded
on Sep. 30, as 100 won per share
Read more
on Sep. 30, as 100 won per share
Read more
DIARY-Malaysia 2016 corporate earnings
Following is a list of release dates for the quarterly earnings
of some top Malaysia-listed companies.
To submit a date, email: ananthalakshmi.as@tr.com
TBD: To be determined
Company RIC PERIOD DATE
AirAsia Bhd Q3 Nov 24
AirAsia X Bhd Q3 Nov 22
AMMB Holdings Bhd Q2 Nov 17-21
Astro Malaysia Holdings Bhd Q3 Dec 6-13
Axiata
Read more
of some top Malaysia-listed companies.
To submit a date, email: ananthalakshmi.as@tr.com
TBD: To be determined
Company RIC PERIOD DATE
AirAsia Bhd Q3 Nov 24
AirAsia X Bhd Q3 Nov 22
AMMB Holdings Bhd Q2 Nov 17-21
Astro Malaysia Holdings Bhd Q3 Dec 6-13
Axiata
Read more
BRIEF-GE Capital completes accelerated bookbuild offering of Moneta Money Bank shares - bookrunner
* Moneta Money Bank AS : bookrunner says GE Capital
International Holdings sold 92.2 million shares of Moneta for
CZK 81/share, proceeds of about CZK 7.5 billion
Read more
International Holdings sold 92.2 million shares of Moneta for
CZK 81/share, proceeds of about CZK 7.5 billion
Read more
Huge study finds a billion people suffer from high blood pressure
LONDON, Nov 16 (Reuters) - The number of people with high
blood pressure has almost doubled in 40 years to over 1.1
billion worldwide, scientists said on Wednesday, with the burden
of the condition shifting from the rich to the poor.
Read more
blood pressure has almost doubled in 40 years to over 1.1
billion worldwide, scientists said on Wednesday, with the burden
of the condition shifting from the rich to the poor.
Read more
BRIEF-Integral Diagnostics secures 5 year contract
* Contract with western australian country health services
(wachs), has been renewed and expanded
Read more
(wachs), has been renewed and expanded
Read more
EU drug agency head fears loss of expert staff after Brexit
LONDON, Nov 15 (Reuters) - The head of Europe's drugs
regulator is braced for disruption following Britain's vote to
leave the European Union (EU) and said he feared losing expert
staff if, as widely expected, the regulator is forced to decamp
from London.
Read more
regulator is braced for disruption following Britain's vote to
leave the European Union (EU) and said he feared losing expert
staff if, as widely expected, the regulator is forced to decamp
from London.
Read more
Generic heart failure drug costs too high for many uninsured-study
NEW ORLEANS, Nov 15 (Reuters) - The cost of generic drugs
that treat heart failure can vary so wildly, even among
pharmacies within one area, that uninsured patients may not be
able to afford them, according to research reported at the
American Heart Association medical meeting in New Orleans on
Tuesday.
Read more
that treat heart failure can vary so wildly, even among
pharmacies within one area, that uninsured patients may not be
able to afford them, according to research reported at the
American Heart Association medical meeting in New Orleans on
Tuesday.
Read more
BRIEF-Germany's Bayer mandatory convertible bond issue covered - source
* 4 billion euro mandatory convertible bond issue covered -
source
(Reporting by Dasha Afanasieva)
Read more
source
(Reporting by Dasha Afanasieva)
Read more
BRIEF-Infusystem Holdings files for non-timely 10-Q
* Files for non-timely 10-q - sec filing
Source text : http://bit.ly/2fRXolq
Further company coverage:
Read more
Source text : http://bit.ly/2fRXolq
Further company coverage:
Read more
Subscribe to:
Posts (Atom)